Now online in @NDTsocial
The FLASH Multiorgan Framework for Assessing High-Flow AV Fistulas in HD
🧐Assessment should move beyond asking how much blood flows through the fistula toward determining how the individual patient responds to that flow.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa…
Nephrology Dialysis Transplantation
The Nephrology Dialysis Transplantation is a monthly peer-reviewed medical journal. It is published by Oxford University Press on behalf of the European Renal Association - European Dialysis and Transplant Association. It is abstracted and indexed in PubMed/MEDLINE/Index Medicus. According to the Journal Citation Reports, the journal has a 2021 impact factor of 7.186. The journal's current editor-in-chief is Denis Fouque (Centre Hospitalier Lyon Sud, Pierre-Bénite, France). More on Wikipedia
-
NDT reposted
Hans-Joachim Anders
@hjanders_hans
-
NDT reposted
Noroژa | Niloufar Ebrahimi
@n0r0zha
💡 What’s the standard in treatment today?
Find out with NDT’s Treatment Standard collection! ✨ @NDTsocial
academic.oup.com/ndt/search-results?f_TocHeadingTitleList…
#nephx -
NDT reposted
YNP of ERA
@ynptweets
1/10 ☕️ Coffee & CKD: yea or nay?
A recent NDT review explores coffee, caffeine and kidney health.
📝 YNP author: @mbigottevieira 🧵 by @jt_nephrology
👇🏻Read more about it in academic.oup.com/ndt/article/41/11/1969/8676382
@NDTSocial @ERAkidney -
NDT
@NDTsocial
Telitacicept targets Gd-IgA1 and autoantibody-producing B cells in IgA nephropathy
doi.org/10.1093/ndt/gfag001 -
NDT
@NDTsocial
Recommendations for pre-analytical urine sample handling to allow optimal assessment of albuminuria and proteinuria
doi.org/10.1093/ndt/gfag083 -
NDT
@NDTsocial
🎥Watch Dr Zhuo Feng present the NDT publication:
Macrophage fate decisions during AKI-CKD transition insights from single-cell and spatial transcriptomics
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=cc4d454… -
NDT
@NDTsocial
Urinary peptidomic classifier for the noninvasive diagnosis of Alport syndrome
🆓doi.org/10.1093/ndt/gfag212 -
NDT
@NDTsocial
Atrial fibrillation in chronic kidney disease - treatment standard
doi.org/10.1093/ndt/gfag263 -
NDT
@NDTsocial
C5a receptor inhibition and minimal steroids for induction of remission in ANCA-associated vasculitis
🆓doi.org/10.1093/ndt/gfag262 -
NDT
@NDTsocial
IDF Diabetes Atlas 11th edition 2025:
European prevalence and projections of CKD in patients with diabetes for 2050
doi.org/10.1093/ndt/gfag260 -
NDT
@NDTsocial
Burden of pruritus in older non-dialysis CKD stage 4-5 patients: 7-year follow-up of the EQUAL study
doi.org/10.1093/ndt/gfag256 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
The highly sensitized kidney transplant candidate - Treatment Standard
🧐Shifting from transient antibody reduction towards deeper and potentially durable remodeling of humoral alloimmune memory
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag258/9027740 -
NDT
@NDTsocial
Trends in nephrology:
from nihilism to targeted treatment of antibody-mediated rejection
🆓doi.org/10.1093/ndt/gfag011 -
NDT
@NDTsocial
Filtering the 2026 ACC/AHA guidelines of dyslipidaemia management: what nephrologists need to know
🆓doi.org/10.1093/ndt/gfag161 -
NDT
@NDTsocial
🎦Watch Dr Michele Barbarini present the NDT publication:
C5 inhibition for anti-cancer therapy-induced renal thrombotic microangiopathy: a cohort study
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=61163a9… -
NDT
@NDTsocial
Coffee consumption and chronic kidney disease
🆓doi.org/10.1093/ndt/gfag107 -
NDT
@NDTsocial
The need for clarity in the nomenclature of kidney cysts
doi.org/10.1093/ndt/gfag163 -
NDT
@NDTsocial
Treatment standards for hypotension on hemodialysis - physiology-based phenotyping of acute and chronic scenarios
doi.org/10.1093/ndt/gfag250 -
NDT
@NDTsocial
😍Check out the new November issue of NDT!
👉academic.oup.com/ndt/issue/41/11 -
NDT
@NDTsocial
Autosomal dominant polycystic kidney disease in Italy
🆓doi.org/10.1093/ndt/gfag255 -
NDT
@NDTsocial
🎦Watch Dr Miguel Hueso present the NDT publication:
Circular RNAs at the crossroads of inflammation, fibrosis and tissue repair
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=880ac0d… -
NDT
@NDTsocial
Efficacy and safety of eculizumab in patients with anti-glomerular basement membrane disease: an investigator-initiated, open-label, phase II clinical trial
doi.org/10.1093/ndt/gfag254 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
The updated global burden of chronic kidney disease: one death every 20 seconds
More info: academic.oup.com/ndt/article/41/10/1899/8497446
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Renal blood flow and progression to kidney failure in ADPKD
More info: academic.oup.com/ndt/article/41/10/1878/8514275
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Traditional Chinese medicine in CKD: myths, facts, and evidence
📖doi.org/10.1093/ndt/gfag247 -
NDT
@NDTsocial
Avacopan across borders: regulatory divergence and treatment dilemmas for ANCA-associated vasculitis
🆓doi.org/10.1093/ndt/gfag253 -
NDT
@NDTsocial
🎥Watch Dr Juan Muñoz-Castañeda present the NDT publication:
FGF23 Blockade Induces Maladaptive Vascular Remodelling, Reducing Pathologically Increased Arterial Stiffness and Blood Pressure
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c376691… -
NDT
@NDTsocial
Circular RNAs at the crossroads of inflammation, fibrosis and tissue repair
doi.org/10.1093/ndt/gfag251 -
NDT
@NDTsocial
Long-term cost-effectiveness of CKD screening in middle-aged adults
doi.org/10.1093/ndt/gfag252 -
NDT
@NDTsocial
Trends in nephrology: tolerance induction through hematopoietic chimerism in kidney transplantation
doi.org/10.1093/ndt/gfag248 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Combination pharmacotherapy in type 2 diabetes and chronic kidney disease: translating evidence into clinical practice
More info: academic.oup.com/ndt/article/41/10/1927/8763805
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Per-protocol repeat kidney biopsy in lupus nephritis: one more branch of the tree
doi.org/10.1093/ndt/gfag249 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘🫘Non immunosuppressive supportive management in IgA Nephropathy
academic.oup.com/ndt/article/41/Supplement_1/i27/8307504?…
@NDTsocial -
NDT
@NDTsocial
BK Polyomavirus-associated nephropathy – diagnostic and treatment standard
doi.org/10.1093/ndt/gfaf002 -
NDT
@NDTsocial
C3G and Ig-MPGN—treatment standard
🆓doi.org/10.1093/ndt/gfad182 -
NDT
@NDTsocial
IgA nephropathy in adults—treatment standard
🆓doi.org/10.1093/ndt/gfad146 -
NDT
@NDTsocial
🎥Watch Dr Kianoush Kashani present the NDT publication:
Pathophysiology of pregnancy-associated acute kidney injury
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=6c1c637… -
NDT
@NDTsocial
High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study
🔓doi.org/10.1093/ndt/gfag240 -
NDT
@NDTsocial
Recombinant shingles vaccination and the risk of cardiovascular events: association or causation?
doi.org/10.1093/ndt/gfag242 -
NDT
@NDTsocial
From stone removal to disease management: do the 2026 EAU Guidelines call for a new Urology–Nephrology partnership?
doi.org/10.1093/ndt/gfag241 -
NDT reposted
Ivan Velázquez
@Nephro_Ivan
Buenísima foto de la fisiopatología y hits de la NIgA, así como los blancos terapéuticos 🤩🤩
🙌🏻🙌🏻
@NDTsocial -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Kidney–heart crosstalk: the extracellular vesicles connection
More info: academic.oup.com/ndt/article/41/8/1399/8469385
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
We don't have this problem here; even salt tablets are reimbursed! Read this nice editorial @NDTsocial titled: Essential but elusive: the availability of suitable salt treatments for tubulopathies @hjanders_hans
academic.oup.com/ndt/article/41/10/1768/8702388 -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
This is not new, but it is reassuring. However, where can ARA be done? We don't have that test.
@NDTsocial @hjanders_hans
academic.oup.com/ndt/article-abstract/41/10/1849/8519153 -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
This is worth considering!
@NDTsocial @hjanders_hans
academic.oup.com/ndt/article-abstract/41/10/1828/8516488 -
NDT
@NDTsocial
Aldosterone and Residual Cardiorenal Risk: Pathophysiology and Emerging Therapeutic Strategies
doi.org/10.1093/ndt/gfag243 -
NDT
@NDTsocial
Long forms of cardiac troponin T are independent of kidney function and improve the diagnosis of myocardial infarction
🆓doi.org/10.1093/ndt/gfag239 -
NDT
@NDTsocial
What do clinical trials teach us about the pathophysiology of human IgA nephropathy?
doi.org/10.1093/ndt/gfaf144 -
NDT
@NDTsocial
How should we best manage the consequences of nephron loss in IgAN?
doi.org/10.1093/ndt/gfaf225 -
NDT
@NDTsocial
🎥Watch Dr Jenny Wrackefeldt present the NDT publication:
The evolution of symptom burden in older men and women with advanced CKD
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=ae1577a… -
NDT
@NDTsocial
KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP)
doi.org/10.1093/ndt/gfag014 -
NDT
@NDTsocial
Bone turnover markers in the management of CKD-associated osteoporosis — a European consensus
doi.org/10.1093/ndt/gfag033 -
NDT
@NDTsocial
Extrarenal disease in ANCA-associated vasculitis:
challenges and evolving therapeutic strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA
doi.org/10.1093/ndt/gfag077
@ERAkidney -
NDT
@NDTsocial
Pregnancies in living kidney donors
doi.org/10.1093/ndt/gfag080 -
NDT
@NDTsocial
KDM1A regulates nephron progenitor programs and is associated with human kidney disease risk
doi.org/10.1093/ndt/gfag073 -
NDT
@NDTsocial
Kidney biopsy during pregnancy: indications, complications, results, and therapeutic impact
doi.org/10.1093/ndt/gfag108 -
NDT
@NDTsocial
When a rare disease lights up the road of common CKD: lessons from HNF1B
doi.org/10.1093/ndt/gfag225 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls
More info: academic.oup.com/ndt/article-abstract/41/8/1436/8424281
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
Jasmine Sethi
@JasmineNephro
🩸Anemia in CKD Management
@NDTsocial
academic.oup.com/ndt/article/39/5/770/7452913?login=false -
NDT
@NDTsocial
Association between multimorbidity and discordance between creatinine- and cystatin C-based eGFR
doi.org/10.1093/ndt/gfag232 -
NDT
@NDTsocial
Macrophage fate decisions during AKI-CKD transition insights from single-cell and spatial transcriptomics
doi.org/10.1093/ndt/gfag236 -
NDT
@NDTsocial
📣NEW Review:
Debating targets for systolic blood pressure lowering in CKD
📖doi.org/10.1093/ndt/gfag233 -
NDT
@NDTsocial
IgG4-related kidney disease: treatment standard
doi.org/10.1093/ndt/gfag235 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Urinary CXCL-9 outperforms TNF-α for non-invasive diagnosis of immune checkpoint inhibitor–associated acute interstitial nephritis
More info: academic.oup.com/ndt/article-abstract/41/8/1457/8465384
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
New kidneys, old risks: cardiovascular challenges after transplantation
doi.org/10.1093/ndt/gfaf239 -
NDT
@NDTsocial
Delisting strategies in highly sensitised kidney transplant candidates
🆓doi.org/10.1093/ndt/gfag229 -
NDT
@NDTsocial
From prematurity and low birth weight to CKD: opportunities for intervention
doi.org/10.1093/ndt/gfag230 -
NDT
@NDTsocial
Impact of selection bias on the association of kidney function polygenic scores with CKD progression in populations with CKD
🆓doi.org/10.1093/ndt/gfag224 -
NDT
@NDTsocial
GATM-mediated creatine synthesis alleviates acute kidney injury by promoting lipophagy in renal tubular epithelial cells
doi.org/10.1093/ndt/gfag226 -
NDT
@NDTsocial
Heart failure in chronic kidney disease: what the Second Universal Definition changes
doi.org/10.1093/ndt/gfag227 -
NDT
@NDTsocial
Renal blood flow and progression to kidney failure in ADPKD
doi.org/10.1093/ndt/gfag059 -
NDT
@NDTsocial
The evolution of symptom burden in older men and women with advanced CKD
doi.org/10.1093/ndt/gfag045 -
NDT
@NDTsocial
Renal gluconeogenesis: a key metabolic hub in health and kidney disease
🆓doi.org/10.1093/ndt/gfag092 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
How to treat “FSGS”? A conceptual framework
🧐This concept helps navigating “FSGS”at kidney biopsy by respecting its need for CKD care + the diagnostic workup needed to identify the correct Tx for causative diseases.
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag187/8766025 -
NDT
@NDTsocial
Complement activation in secondary thrombotic microangiopathies
doi.org/10.1093/ndt/gfaf091
This review summarizes the current understanding and future directions in the management of secondary TMA, emphasizing the potential of complement inhibition as a therapeutic strategy. -
NDT
@NDTsocial
Transition of patients with hereditary nephropathies from paediatric to adult care
doi.org/10.1093/ndt/gfaf186
📸Schematic representation of decision-making processes involved in genetic diagnosis and counselling during the transition period -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Anti-nephrin antibodies disrupt slit diaphragm geometry, as revealed by cryo-electron tomography
🧐The cryo-ET–based findings suggest how antibody binding to nephrin can translate into podocyte architectural failure.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Beyond Kt/V: Redefining Dialysis Adequacy as Targeted CV Risk Reduction
🧐 Future trials should be multicenter, phenotype-enriched, mechanism-specific, adequately powered, and endpoint-adjudicated.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
🧐Check out the new October issue of NDT!
📖academic.oup.com/ndt/issue
📢Editor's choice:
CKD-associated osteoporosis in patients with CKD G4-5D: a pragmatic treatment approach
🆓doi.org/10.1093/ndt/gfag124 -
NDT
@NDTsocial
Protocol kidney biopsy in the management of proliferative (class III/IV) lupus nephritis: barking up the wrong tree!
doi.org/10.1093/ndt/gfag207 -
NDT
@NDTsocial
A new dimension in hemodialysis: integrating art into clinical outcomes
doi.org/10.1093/ndt/gfag143 -
NDT
@NDTsocial
European epidemiology of kidney cancer
doi.org/10.1093/ndt/gfag216 -
NDT
@NDTsocial
Obesity and chronic kidney disease: a cardio-kidney-metabolic framework for renal vulnerability and risk stratification
doi.org/10.1093/ndt/gfag221 -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
Indexing for body surface area when assessing kidney function @NDTsocial @hjanders_hans academic.oup.com/ndt/article/41/9/1595/8530518
-
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
Interesting debate regarding the use of Hematuria as a biomarker guiding treatment decisions in IgA nephropathy @NDTsocial @IgAN_JBarratt @hjanders_hans
academic.oup.com/ndt/article/41/9/1592/8539734?login=true
academic.oup.com/ndt/article/41/9/1589/8537765 -
NDT
@NDTsocial
Antithrombotic therapy in CKD after the 2026 ESC guidelines: clarity versus certainty
doi.org/10.1093/ndt/gfag218 -
NDT
@NDTsocial
Unmet needs in the management of adult patients with lupus nephritis
doi.org/10.1093/ndt/gfag220 -
NDT
@NDTsocial
FGF23 blockade induces maladaptive vascular remodelling, reducing pathologically increased arterial stiffness and blood pressure
doi.org/10.1093/ndt/gfag215 -
NDT
@NDTsocial
Chronic Kidney Disease of unexplained cause (CKDx):
a consensus statement by the Genes & Kidney Working Group of the ERA
doi.org/10.1093/ndt/gfaf092 -
NDT
@NDTsocial
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD
doi.org/10.1093/ndt/gfaf151 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘CKD of Unknown origin-Management
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfag…
@NDTsocial -
NDT
@NDTsocial
❤️Check out the NDT kidney art gallery❤️
www.era-online.org/ndt-kidney-art-gallery/
🤩Do you also want your work to be featured on one of the next NDT covers?
📢Just send it to the NDT Editorial Office! -
NDT
@NDTsocial
Creatinine, cystatin C or both to estimate glomerular filtration rate in kidney transplant recipients?
doi.org/10.1093/ndt/gfag037 -
NDT
@NDTsocial
Admission kidney tubule biomarkers do not predict acute kidney injury or in-hospital adverse events in acute heart failure
doi.org/10.1093/ndt/gfag079 -
NDT
@NDTsocial
Sparsentan - SGLT2 inhibitor combination therapy in trials of IgA nephropathy
🔓doi.org/10.1093/ndt/gfag211 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Renal functional reserve predicts GFR response to empagliflozin in RENALIS and RACELINES clinical trials
More info: academic.oup.com/ndt/article/41/8/1520/8471545
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Efficacy and safety of finerenone in non-diabetic patients with IgA nephropathy
More info: academic.oup.com/ndt/article-abstract/41/8/1508/8466413
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
IgA nephropathy occurrence, treatment, and prognosis in the last two decades in Denmark
More info: academic.oup.com/ndt/article-abstract/41/8/1496/8466412
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Single-nephron eGFR and kidney function decline in IgA nephropathy
More info: academic.oup.com/ndt/article-abstract/41/8/1482/8454926
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Protocol kidney biopsy in the management of proliferative (class III/IV) lupus nephritis: barking up the wrong tree!
🔓doi.org/10.1093/ndt/gfag207 -
NDT
@NDTsocial
Chronic kidney disease of unknown origin – management proposal
doi.org/10.1093/ndt/gfag196 -
NDT
@NDTsocial
Nouakchott Declaration: Promoting Organ Donation and Transplantation in Africa
doi.org/10.1093/ndt/gfag209 -
NDT
@NDTsocial
Risk factor obesity: treatment standard
doi.org/10.1093/ndt/gfag164 -
NDT
@NDTsocial
🧐Pro / Con:
Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? No
doi.org/10.1093/ndt/gfag071
Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? Yes
doi.org/10.1093/ndt/gfag072 -
NDT
@NDTsocial
🎥Watch Dr Thomas Rauen present the NDT publication:
Serum levels of guanidinylated YB-1 indicate active lupus nephritis
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=24c82fa… -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Renal and urothelial cancer risks with SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes: a target trial emulation
More info: academic.oup.com/ndt/article-abstract/41/8/1543/8471556
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Membranous nephropathy treatment standard
doi.org/10.1093/ndt/gfad225
All the NDT treatment standards can be viewed here:
👇👇👇
academic.oup.com/ndt/search-results?f_TocHeadingTitleList… -
NDT
@NDTsocial
C3G and Ig-MPGN—treatment standard
🔓doi.org/10.1093/ndt/gfad182 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Biomarker-guided polymyxin B haemoadsorption in endotoxic septic shock
🧐Tigris provides new prospective randomised support for PMX-HA in an endotoxin activity-assay-guided population with septic schock
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag205/8785778 -
NDT reposted
Gunnar Henrik Heine
@gunnar_heine
Retrospective cohort data suggest Infliximab to outperform steroids alone for the treatment of ICI-AKI by Rishi R Patel @ArashRashidi14 et al
@NDTsocial @HerrmannMd @hjanders_hans
academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Brendon Neuen
@brendonneuen
Benefits of SGLT2i exceed serious harms regardless of polypharmacy status, with greatest absolute effects in patients with higher medication burden
New CREDENCE analysis from @emilykyeung in @NDTsocial doi.org/10.1093/ndt/gfag203 -
NDT
@NDTsocial
Biomarker-guided polymyxin B haemoadsorption in endotoxic septic shock
doi.org/10.1093/ndt/gfag205 -
NDT
@NDTsocial
Antibody-mediated rejection—treatment standard
doi.org/10.1093/ndt/gfaf097 -
NDT
@NDTsocial
KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP)
doi.org/10.1093/ndt/gfag014 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Specific aspects of kidney care for Africans living in Europe
🧐Key causes & diagnostic challenges specific to Africans in Europe as well as genetic, clinical, and community-based strategies for equitable kidney care
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag204/8781081 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Cardiovascular outcomes and acute kidney injury risk with combination therapies in type 2 diabetes and chronic kidney disease
More info: academic.oup.com/ndt/article-abstract/41/8/1573/8654258
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Trends in nephrology: How to advance kidney medicine in public healthcare
🧐 Primary and secondary prevention of CVD is accepted by society at large and national governments. We need the same for CKD.
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag201/8781085 -
NDT
@NDTsocial
Acute post-streptococcal glomerulonephritis in children— treatment standard
🔓doi.org/10.1093/ndt/gfaf130 -
NDT
@NDTsocial
🎥Watch Dr Julia Kerschbaum present the NDT publication:
Prevalence, patient burden and physicians’ perception of pruritus in hemodialysis patients
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=0a73500… -
NDT
@NDTsocial
Cullin 3 ubiquitin ligase regulates redox defense and metabolic programs in proximal tubule cells
🔓doi.org/10.1093/ndt/gfag202 -
NDT
@NDTsocial
Life support in hemodialysis emergencies—treatment standard
doi.org/10.1093/ndt/gfaf136 -
NDT
@NDTsocial
Association of UACR and UPCR with kidney failure: analysis of observational data in patients with rare kidney diseases
doi.org/10.1093/ndt/gfag066 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Sex in CKD trials: representation and treatment effects of cardiorenoprotective therapies
🧐Women remain underrepresented in cardiorenoprotective therapy trials, with limited sex-specific outcome reporting
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag199/8776679 -
NDT
@NDTsocial
Novel protein biomarkers for risk stratification and personalized medicine
🔓doi.org/10.1093/ndt/gfag068 -
NDT
@NDTsocial
Recommendations for pre-analytical urine sample handling to allow optimal assessment of albuminuria and proteinuria
doi.org/10.1093/ndt/gfag083 -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
Thanks for the notice Dr. Glassock, I missed this one.
Here is the link @NDTsocial
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfag… -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
An extensive thorough report from the ERA and the EKITA about the Management of antithrombotic therapies in kidney transplantation candidates and recipients recently published in th @NDTsocial @hjanders_hans
academic.oup.com/ndt/article/41/9/1736/8469372 -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
I like how they assess the bone health of dialysis patients
risk factors
calcium intake
mineral metabolism parameters
bone turnover markers
fracture Hx
BMD and vertebral fractures by DXA
handgrip strength
physical activity
@hjanders_hans @NDTsocial
academic.oup.com/ndt/article/41/9/1719/8496066 -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
A recently published debate on @NDTsocial September issue on the use of Hematuria as a biomarker guiding treatment decisions in IgA nephropathy, are you with or against? @hjanders_hans
academic.oup.com/ndt/article/41/9/1589/8537765
academic.oup.com/ndt/article/41/9/1592/8539734 -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
An outstanding review of the use of BSA-indexed eGFR published @NDTsocial in the September issue. Enjoy thew reading. @hjanders_hans
academic.oup.com/ndt/article/41/9/1595/8530518 -
NDT reposted
Noroژa | Niloufar Ebrahimi
@n0r0zha
The newly published NDT Supplement brings together the latest evidence and perspectives from the NKF 2025 Albuminuria–Proteinuria Workshop @NDTsocial @NKF_NephPros
academic.oup.com/ndt/issue/41/Supplement_2 -
NDT reposted
Noroژa | Niloufar Ebrahimi
@n0r0zha
Ain’t no way kidneys were ever meant to look this fabulous.
September issue of NDT is here! 🫘 @NDTsocial -
NDT reposted
Nikhil Shah MBBS DNB(IM, Neph)🇨🇦
@dr_nikhilshah
Peritoneal Dialysis bi-weekly update · 6 papers audioscholar.cc/episode/rygfkw73ff
#peritonealdialysis update.
#audioscholar
@PD_Perls @asnpublications @NDTsocial @seminarsneph
@pdi_journal -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🧩 Obesity management is multidimensional:
🥗 Diet → 🏃 Exercise → ⚖️ Weight loss
💊 GLP-1/GIP therapies
🩺 ACEi/ARB + SGLT2i for kidney protection
🦠 Gut microbiome
📊 Risk stratification
🏥 Bariatric surgery when appropriate
🔗 doi.org/10.1093/ndt/gfag164 -
NDT reposted
Nikhil Shah MBBS DNB(IM, Neph)🇨🇦
@dr_nikhilshah
Specialty Weekly: nephrology · 10 papers
#thisweekinnephrology
#audioscholar audioscholar.cc/episode/uemahvbg9y
Features papers from - @asnpublications @NDTsocial @amjtransplant @Kidney_Int @bmj_latest -
NDT
@NDTsocial
Serum levels of guanidinylated YB-1 indicate active lupus nephritis
🔓doi.org/10.1093/ndt/gfag195 -
NDT
@NDTsocial
Comparative effectiveness of combination therapy in patients with chronic kidney disease and diabetes mellitus type 2 using real world data
doi.org/10.1093/ndt/gfag198 -
NDT
@NDTsocial
🤩The September issue is online!
📖academic.oup.com/ndt/issue/41/9
🧐Editor's choice:
Over 500 000 people on kidney replacement therapy in the European Union
🆓doi.org/10.1093/ndt/gfag017 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
GLP-1ra are associated with lower kidney cancer risk after metabolic bariatric surgery
🧐GLP-1ra show oncologic safety and benefits beyond glycemic control
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Marco Bonilla
@Nephr0s
Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessment academic.oup.com/ndt/article/41/Supplement_2/ii1/8684958 @NDTsocial @hjanders_hans
-
NDT
@NDTsocial
🧐NEW Supplement:
Measuring albuminuria or proteinuria to diagnose and monitor CKD - Results from the NKF 2025 Albuminuria–Proteinuria Workshop
➡️It addresses methodological, clinical, analytical & translational dimensions of urinary protein assessment
l1nq.com/kqvcvv4 -
NDT
@NDTsocial
🎦Watch Dr Christian Eichhorn present the NDT publication:
Risk of CKD in Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=90ffe08… -
NDT
@NDTsocial
Hepatic injury-induced remote kidney injury is associated with impaired hepatic clearance of cell-free hemoglobin
📖doi.org/10.1093/ndt/gfag190 -
NDT
@NDTsocial
Spatial and seasonal patterns of pediatric idiopathic nephrotic syndrome in France
doi.org/10.1093/ndt/gfag193 -
NDT
@NDTsocial
Urinary Dickkopf-3 as a biomarker for kidney-function decline: a systematic review and meta-analysis
doi.org/10.1093/ndt/gfag178 -
NDT
@NDTsocial
Combination Pharmacotherapy in Type 2 Diabetes and Chronic Kidney Disease: Translating Evidence into Clinical Practice
🆓doi.org/10.1093/ndt/gfag136 -
NDT
@NDTsocial
🎥Watch Dr Jenny Wrackefeldt present the NDT publication:
The evolution of symptom burden in older men and women with advanced CKD
⬇️⬇️⬇️
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=ae1577a… -
NDT
@NDTsocial
Longitudinal eGFR data in the estimation of missing baseline eGFR in patients with glomerular disease
🔓doi.org/10.1093/ndt/gfag194 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🧬 When should kidney biopsy trigger genetic testing?
🔬 Clues:
➡️ GBM changes → Alport
➡️ Podocyte inclusions → Fabry
➡️ C3G • TMA • Amyloid
➡️ Unexplained FSGS/scarring
Biopsy → phenotype → genetics🧬
#nephrology #renalpath #genetics @NDTsocial
doi.org/10.1093/ndt/gfag047 -
NDT
@NDTsocial
🎥Watch Dr Noemie Jourde present the NDT publication:
Kidney biopsy during pregnancy: indications, complications, results and therapeutic impact
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=70f9506… -
NDT
@NDTsocial
NEW Review:
Chronic kidney disease, atrial fibrillation, and stroke: risk scores in the era of SGLT2i, non-steroidal MRA, and GLP-1 RA, and presence of high competing mortality
📖doi.org/10.1093/ndt/gfag191 -
NDT
@NDTsocial
🎥Watch Dr Kianoush Kashani present the NDT publication:
Pathophysiology of Pregnancy-Associated Acute Kidney Injury
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=6c1c637… -
NDT
@NDTsocial
Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillation
🆓doi.org/10.1093/ndt/gfae121 -
NDT
@NDTsocial
Trends in mortality in adult first kidney transplant recipients with and without diabetes as cause of kidney failure: an ERA Registry study
doi.org/10.1093/ndt/gfag188
@ERAkidney -
NDT
@NDTsocial
How to treat „FSGS“? A conceptual framework
🆓doi.org/10.1093/ndt/gfag187
@hjanders_hans -
NDT
@NDTsocial
🎥Watch Dr Ryunosuke Mitsuno present the NDT publication:
Parkinson disease imposes risk of kidney function decline
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f39bab2… -
NDT
@NDTsocial
Reframing kidney outcomes in CKD trials: 2
eGFR slopes, competing risks, and pragmatic trial design
doi.org/10.1093/ndt/gfag176 -
NDT reposted
Sayna Norouzi, MD, FASN
@SaynaNorouzi
#obesity is a major challenge in #kidneydisease care and the management is changing.
We’re suggesting mechanism-based risk stratification over one-size-fits-all treatment.
Thank you @NDTsocial for the opportunity. 🙌🏻
@AKronbichler @edgarvlermamd @GivHeidariMD ✨⭐️ -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Reframing kidney outcomes in CKD trials: eGFR slopes, competing risks, and pragmatic trial design
🧐To advance nephrology research, we should embrace innovative study designs and methodologies.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Jasmine Sethi
@JasmineNephro
AKI → CKD: How does it happen? 🫘🩺
academic.oup.com/ndt/advance-article-abstract/doi/10.1093…
@NDTsocial -
NDT
@NDTsocial
The changing global epidemiology of obesity
doi.org/10.1093/ndt/gfag186 -
NDT
@NDTsocial
RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1
doi.org/10.1093/ndt/gfaf202 -
NDT
@NDTsocial
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index
🔓doi.org/10.1093/ndt/gfaf197 -
NDT
@NDTsocial
🎥Watch Dr Aglaia Chalkia present the NDT publication:
Extrarenal disease in ANCA-associated vasculitis: challenges and evolving therapeutic strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA
@ERAkidney
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=4dd8002… -
NDT
@NDTsocial
🎥Watch Dr Luigi Cirillo present the NDT publication:
Eculizumab for rapidly progressive glomerulonephritis in children
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=e802719… -
NDT
@NDTsocial
RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1
doi.org/10.1093/ndt/gfaf202 -
NDT
@NDTsocial
🎥Watch Dr Judith Boehm to present the NDT publication:
Integrating palliative care into routine nephrology practice
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b4b3282… -
NDT
@NDTsocial
Intestinal paracellular phosphate absorption resists dietary adaptation but is upregulated in CKD
doi.org/10.1093/ndt/gfag185 -
NDT
@NDTsocial
Renin-angiotensin system inhibition in dialysis-dependent patients with chronic heart failure due to reduced ejection fraction: a systematic review and meta-analysis
doi.org/10.1093/ndt/gfag184 -
NDT
@NDTsocial
🥳Become a Reviewer for NDT and join the Reviewer Champions Gallery!
www.era-online.org/reviewer-champions-gallery/
👏The annual Top Reviewers receive a free ERA Congress Registration🙏
@ERAkidney -
NDT
@NDTsocial
🎥Watch Dr Xin Zhang present the NDT publication:
Bortezomib-cyclophosphamide-dexamethasone versus rituximab in PGNMID
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=76c921e… -
NDT
@NDTsocial
👍Editor's Choice from September issue NDT:
KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD):
a commentary from the European Renal Best Practice (ERBP)
doi.org/10.1093/ndt/gfag014 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Exosomes in kidney disease: From Pathophysiology to Diagnostic and Therapeutic Tools
🧐Exosomes have a high translational potential for the diagnosis and treatment of kidney diseases.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
📢NEW publication by the @ERAkidney Immunonephrology Working Group:
Management of Recurrent C3 Glomerulopathy After Kidney Transplantation
🔓doi.org/10.1093/ndt/gfag183 -
NDT
@NDTsocial
NEW Review:
The AKI-CKD continuum: mechanisms and therapeutic interventions
📖doi.org/10.1093/ndt/gfag180 -
NDT
@NDTsocial
NEW Editorial:
Regulatory frameworks and technical bottlenecks for clinical translation of the bioartificial kidney
FREE access:
🔓doi.org/10.1093/ndt/gfag181 -
NDT
@NDTsocial
🎥Watch Dr Jelle Beernink present the NDT publication:
Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c005244… -
NDT
@NDTsocial
Association between anti-rituximab antibodies and treatment efficacy of rituximab in membranous nephropathy
doi.org/10.1093/ndt/gfag054 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Clinical phenotypes and etiologic subtypes of thrombotic microangiopathy in SLE
🧐SLE-TMA is frequently limited to the kidney requiring biopsy for diagnosis. Kidney phenotype identifies subgroups with distinct trajectories
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Integrating palliative care into routine nephrology practice
🆓doi.org/10.1093/ndt/gfag170 -
NDT
@NDTsocial
CKD-guideline adherence in primary and nephrology care for older patients with advanced CKD
🆓doi.org/10.1093/ndt/gfag171 -
NDT
@NDTsocial
Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKD
🔓doi.org/10.1093/ndt/gfag172 -
NDT
@NDTsocial
NEW Review:
CKD screening: urinary albumin or uDKK3 or both?
doi.org/10.1093/ndt/gfag166 -
NDT
@NDTsocial
🎥Watch Dr Ralph Wendt present the NDT publication:
Urea vs Tolvaptan for Hospitalized Patients With SIAD: A Retrospective Cohort Study
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=d5b23e8… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Creatine supplementation in patients with kidney disease - harm or benefit?
🧐Creatine may be a promising nutritional intervention in CKD management
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
2026 ACC/AHA guidelines of dyslipidaemia management for nephrologists
🧐-CKD a major ASCVD RF: treat as such
- Treat-to-target, no more fire-and-forget
- Coronary artery Ca score, Lp(a), and ApoB for risk stratification
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag161/8731932 -
NDT
@NDTsocial
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications
🆓doi.org/10.1093/ndt/gfaf156 -
NDT
@NDTsocial
🎥 Watch Dr Fernando Caravaca-Fontan present the NDT publication:
Pivotal Clinical Trials in C3 Glomerulopathy: Answers and Remaining Uncertainties
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=51662f5… -
NDT
@NDTsocial
🤩Check out the new August issue of NDT:
📖academic.oup.com/ndt/issue/41/8
🧐Editor's choice:
KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP)
🔓doi.org/10.1093/ndt/gfag014 -
NDT
@NDTsocial
SGLT2 inhibitors and acute kidney injury
doi.org/10.1093/ndt/gfaf132 -
NDT
@NDTsocial
IDF Diabetes Atlas 11th edition 2025:
global prevalence and projections for 2050
doi.org/10.1093/ndt/gfaf177 -
NDT
@NDTsocial
The updated global burden of chronic kidney disease: one death every 20 seconds
doi.org/10.1093/ndt/gfag040 -
NDT
@NDTsocial
Filtering the 2026 ACC/AHA guidelines of dyslipidaemia management: what nephrologists need to know
doi.org/10.1093/ndt/gfag161 -
NDT reposted
Gunnar Henrik Heine
@gunnar_heine
A nephrological view on the 2026 ACC/AHA guidelines of dyslipidaemia management
The majority of CKD G 3 plus patients should receive statins (and often also ezetimib)
@NDTsocial @hjanders_hans
@VanAmaryllis
academic.oup.com/ndt/article/doi/10.1093/ndt/gfag161/8731932 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Proteinuria remission and long-term kidney outcome in children with IgAN
🧐55% of children achieve a complete and sustained remission of IgAN
▶️ academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
C5a/C5aR1 mediates AKI-CKD transition by enhancing autophagy
🧐We need C5a/C5aR1 antagonists other than avacopan for kidney diseases
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Jasmine Sethi
@JasmineNephro
🖥️Monitoring after starting RAASi
academic.oup.com/ndt/article/41/7/1227/8659306?login=false
@NDTsocial -
NDT reposted
Edgar V. Lerma 🇵🇭
@edgarvlermamd
Urea vs. tolvaptan for hospitalized patients with SIADH ca. 2026 from @NDTsocial
#nephpearls
👉🏼 pubmed.ncbi.nlm.nih.gov/42455009/ -
NDT
@NDTsocial
Risk factor obesity: treatment standard
🔓doi.org/10.1093/ndt/gfag164 -
NDT
@NDTsocial
Atypical presentation and severity of Dengue fever in patients with CKD
doi.org/10.1093/ndt/gfag151 -
NDT
@NDTsocial
Evidence-Based Medicine versus Personalized Medicine when attempting to block complement in IgA nephropathy
doi.org/10.1093/ndt/gfag159 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Severe Pregnancy-Associated Acute Kidney Injury and Maternal Vulnerability
🧐The incidence of severe PrAKI increased from 9/10,000 pregnancies ( 2012-13) to 27.6/10,000 in the COVID-19 era (2020-22).
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
😍Did you already discover the NDT kidney art gallery?
era-online.org/ndt-kidney-art-gallery/
📷Check it out and send us one of your own kidney images!
😍Selected images appear on the covers of NDT🥳 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🚀 GLP-1RAs are changing medicine! 🩺🫘
✅#t2dm ❤️CV protection ⚖️#obesity 🩺#ckd 😴#osa 🫀#mash
🌟#semaglutide leads approved indications
📈#tirzepatide is catching up fast
🔗doi.org/10.1093/ndt/gfaf199
#nephrology #glp1 -
NDT
@NDTsocial
📢NEW Editorial:
Beyond diffusion and convection: is adsorption the third dimension of dialysis?
doi.org/10.1093/ndt/gfag156 -
NDT
@NDTsocial
🎥Watch Dr Sebastian Bachmann present the NDT publication:
Cyclosporine A- versus tacrolimus-specific lesions in calcineurin inhibitor nephrotoxicity
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=dec63b3… -
NDT
@NDTsocial
Bone turnover markers in the management of CKD-associated osteoporosis — a European consensus
doi.org/10.1093/ndt/gfag033 -
NDT
@NDTsocial
The effect of icodextrin on peritoneal dialysis patients with congestive heart failure: a time-varying exposure design and target trial emulation approach
doi.org/10.1093/ndt/gfaf265 -
NDT
@NDTsocial
RAAS blockade in the kidney life-cycle: treatment standard
🔓doi.org/10.1093/ndt/gfag090 -
NDT
@NDTsocial
Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD
doi.org/10.1093/ndt/gfag150 -
NDT
@NDTsocial
🥳Check out the new July issue of NDT:
academic.oup.com/ndt/issue/41/7 -
NDT
@NDTsocial
🎥Watch Dr Vanessa Marchant present the NDT publication:
Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b897c59… -
NDT
@NDTsocial
Prevalence of anti-rituximab antibodies in autoimmune forms of glomerulonephritis and podocytopathies
🔓doi.org/10.1093/ndt/gfag137 -
NDT
@NDTsocial
Pathophysiology of pregnancy-associated acute kidney injury
doi.org/10.1093/ndt/gfag142 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🩺 PTDM management in kidney transplant recipients 🫘
✅ CKD/HF → SGLT2i
✅ Obesity/ASCVD → GLP-1RA
✅ Unstable graft function → Insulin
The right drug —> right patient: optimize both metabolic and Tx outcomes
🔗 doi.org/10.1093/ndt/gfad258
#nephrology #ptdm #nephtwitter -
NDT
@NDTsocial
Difelikefalin-associated adverse drug event signals: a real-world pharmacovigilance study from the FAERS database
doi.org/10.1093/ndt/gfag144 -
NDT
@NDTsocial
Risk of CKD in biopsy-proven metabolic dysfunction-associated steatotic liver disease
doi.org/10.1093/ndt/gfag147 -
NDT
@NDTsocial
🎥Watch Dr Stephen Duff present the NDT publication:
Admission kidney tubule biomarkers do not predict acute kidney injury or in-hospital adverse events in acute heart failure
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=5ce2209… -
NDT
@NDTsocial
❤️Check out our new ERA and ESC cardio-kidney Collection!
@escardio @ERAkidney
academic.oup.com/ndt/pages/joint-era-and-esc-cardio-kidne…
🧐Selected from this collection:
GLP-1-based therapeutics for cardiorenal protection in metabolic diseases
🔓doi.org/10.1093/ndt/gfaf110 -
NDT
@NDTsocial
FINE-ONE, more to come: moving beyond ACEis and ARBs in type 1 diabetes with kidney disease?
🆓doi.org/10.1093/ndt/gfag140 -
NDT
@NDTsocial
🎥Watch Dr Francesco Pesce present the NDT publication:
Bayesian Methods in Nephrology:
Applications in Adaptive Trials, Dynamic Risk Prediction, Pharmacokinetics, and Causal Inference
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=0c0b22d… -
NDT
@NDTsocial
A life course approach to preventing chronic kidney disease by limiting long-term consequences of early adverse events
🔓doi.org/10.1093/ndt/gfag133 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
CsA vs Tac: Specific histopathological lesions in CNI nephrotoxicity
🧐CsA: proximal tubule epithelia affected more
Tac: Glomerular scarring and interstitial microvascular lesions
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Essential but elusive: the availability of suitable salt treatments for tubulopathies
🧐 The availability of salt supplements can be problematic but is of direct importance to QOL and long-term outcome of pts
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag097/8702388 -
NDT reposted
Gunnar Henrik Heine
@gunnar_heine
Join us Friday 7:15 CEST
Best of #era2026 @MarkusAtHome
@DrBradleyDixon Prof Segelmark Prof Willcocks @fervenzaf @BondGregor @HeerspinkHiddo
@brendonneuen @torra_roser
@hjanders_hans @AKronbichler Caro Schneppe
Partner: @NDTsocial @ERAkidney
youtu.be/OxbYH9yOd6w via @YouTube -
NDT reposted
Roser Torra
@torra_roser
Do not miss it! Fabulous summary and discussion of some of the best LBT at @ERAkidney congress. @NDTsocial
Gunnar Henrik Heine
@gunnar_heine
Join us Friday 7:15 CEST
Best of #era2026 @MarkusAtHome
@DrBradleyDixon Prof Segelmark Prof Willcocks @fervenzaf @BondGregor @HeerspinkHiddo
@brendonneuen @torra_roser
@hjanders_hans @AKronbichler Caro Schneppe
Partner: @NDTsocial @ERAkidney
youtu.be/OxbYH9yOd6w via @YouTube -
NDT reposted
Oxford Academic
@OUPAcademic
Looking for the latest research in #nephrology?
Explore the most read and most cited papers from the past year in Nephrology Dialysis Transplantation.
Read now: oxford.ly/4xi4beu
@NDTsocial
@ERAkidney -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Peptide Epitope Mapping of Anti-nephrin antibodies in FSGS
🧐Patient plasma binding was restricted to a small subset of nephrin peptides
▶️ academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Gunnar Henrik Heine
@gunnar_heine
Find all our webinars from our
@NDTsocial @MarkusAtHome collaboration
at youtube.com/playlist?list=PLIXz8KaG3dGflUgmepVn9-dSKQEyzq3Q8
Thanks again to @hjanders_hans
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Trends in Nephrology: from treating kidney disease to maintaining kidney health
🧐KDIGO replaced the passive term “screen” by the active term “prevent”!
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag129/8706378 -
NDT reposted
Johann Morelle
@JohannMorelle
Infection risk mitigation with #complement inhibitors in #kidney disease
✅ Final version available in @NDTsocial, the official journal of @ERAkidney
➡️ academic.oup.com/ndt/advance-ar…
🙏 Grateful to all co-authors, incl. @smirioglu @AKronbichler
#tma #ahus #c3g #icmpgn #igan -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Bleeding risk after kidney biopsy with platelet inhibition
🧐Platelet inhibition is not associated with increased risk of serious complications after kidney biopsy.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial @PStoneOftheYear @GlassockJ
GFR indexing per Body surface area –Why, how and when?
🧐The difficulty lies not just in the methodology, but in the weight of tradition; it is remarkably difficult to alter practices
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag138/8707249 -
NDT
@NDTsocial
😳The updated global burden of chronic kidney disease: one death every 20 seconds
doi.org/10.1093/ndt/gfag040 -
NDT
@NDTsocial
📹Watch Dr Daniel Kraus present the NDT publication:
Bleeding risk after kidney biopsy with platelet inhibition
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f50067d… -
NDT
@NDTsocial
Chronic Kidney Disease of unexplained cause (CKDx):
a consensus statement by the Genes & Kidney Working Group of the ERA
🔓doi.org/10.1093/ndt/gfaf092
@ERAkidney -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online at @NDTsocial @gunnar_heine @AKronbichler @ERAkidney
NDT and MARKUS@HOMe partnership
🧐Journal-affiliated YouTube channels are a promising strategy to disseminate high-quality medical content beyond conventional publication formats
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag132/8706388 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Trends in Nephrology: from treating kidney disease to maintaining kidney health
🧐KDIGO replaced the passive term “screen” by the active term “prevent”!
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag129/8706378 -
NDT
@NDTsocial
🥳THANK YOU to the top NDT Reviewers of 2025🥳
Jan Halbritter
Kaitlin Mayne
Manuel Praga
😍Those present at the ERA Congress in Glasgow received a certificate from the Editor-in-Chief and a free Congress registration😍 -
NDT
@NDTsocial
Cyclosporin A- versus tacrolimus-specific lesions in calcineurin inhibitor nephrotoxicity
📖doi.org/10.1093/ndt/gfag126 -
NDT
@NDTsocial
🙏THANK YOU to the 2025-2026 NDT Editorial Fellows!
🫶Our amazing Fellows received a certificate from the Editor-in-Chief during the NDT Editorial Board meeting at the ERA Congress in Glasgow
♥️Thank you all for your support, also to those who could not be present in person -
NDT
@NDTsocial
IDF Diabetes Atlas 11th edition 2025:
global prevalence and projections for 2050
doi.org/10.1093/ndt/gfaf177 -
NDT
@NDTsocial
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD
🆓doi.org/10.1093/ndt/gfaf151 -
NDT
@NDTsocial
📢One of the most cited NDT papers:
Global epidemiology of kidney cancer
🆓doi.org/10.1093/ndt/gfae036 -
NDT reposted
Noroژa | Niloufar Ebrahimi
@n0r0zha
Today, at the NDT Editorial Board Meeting during the #era26 Congress in Glasgow, NDT Editor-in-Chief Prof. Anders addressed the journal’s recent achievements and outlined its future strategic priorities.✨ @NDTsocial @ERAkidney @hjanders_hans
-
NDT
@NDTsocial
🎥Watch Dr Wendy Mccallum present the NDT publication:
Acute declines in kidney function with thiazide plus loop diuretics vs loop diuretics alone in acute decompensated heart failure
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=5989aee… -
NDT
@NDTsocial
Kidney replacement therapy trajectories of patients with kidney failure: an ERA Registry study
🔓doi.org/10.1093/ndt/gfaf236 -
NDT
@NDTsocial
Randomized controlled trials in Europe:
a call to action to protect national healthcare systems from the upcoming tsunami of kidney failure
🔓doi.org/10.1093/ndt/gfag007 -
NDT reposted
Safak Mirioglu
@smirioglu
🦠 An important issue considering the recently approved and upcoming #complement blockers.
Glad to be part of it! Led by brilliant @JohannMorelle.
@AKronbichler @NDTsocial
Johann Morelle
@JohannMorelle
Infection Risk Mitigation with Complement Inhibitors in Kidney Disease
Delighted to share our latest work, now online in NDT, the official journal of the @ERAkidney
🙏 Mathilde Berghmans, Francois Seghers, @AKronbichler @smirioglu
academic.oup.com/ndt/advance-article-abstract/doi/10.1093… -
NDT reposted
Edgar V. Lerma 🇵🇭
@edgarvlermamd
Diabetic Nephropathy (DN) with concurrent primary podocytopathy represents a distinct clinical entity characterized by nephrotic-range proteinuria, ultrastructural podocyte effacement and favorable response to immunosuppressive therapy ca. 2026 from @NDTsocial
#nephpearls #ecneph
Early renal biopsy incorporating Foot Process Width (FPW) assessment enables targeted therapy to mitigate ESKD progression in this high-risk phenotype.
pubmed.ncbi.nlm.nih.gov/41818335/ -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🎯 #igan therapy is moving upstream to B-cell biology
BAFF/APRIL blockade targets survival signals driving IgA Nephrology
#telitacicept adds to the precision-treatment era in IgA nephropathy
🔗 doi.org/10.1093/ndt/gfag001
@NDTsocial #nephrology -
NDT reposted
Akshaya Jayachandran 🇮🇳
@DrAkshayaJ
1/7 ☕️🩺 “Can my CKD patients still drink coffee?”
The evidence is getting more interesting than expected
This review in @NDTsocial ➡️ Moderate coffee intake is probably safe in CKD, may even be beneficial.
@ERAkidney
doi.org/10.1093/ndt/gfag107
I'm a☕️addict, couldn't help tweet. -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Sex, menopause and CKD in primary care
🧐Women are protected before midlife, but this advantage disappears beyond age 50 years. Seems CKD works like atherosclerosis/CVD
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Renal gluconeogenesis: a key metabolic hub in health and kidney disease
🧐The kidney as a major site of endogenous glucose production and coupled to ammoniagenesis and tricarboxylic acid cycle beyond glucose homeostasis
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag092/8697342 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🧬Complement pathway and Inhibitors
academic.oup.com/ndt/advance-article-abstract/doi/10.1093…
@NDTsocial -
NDT
@NDTsocial
KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD):
a commentary from the European Renal Best Practice (ERBP)
🔓doi.org/10.1093/ndt/gfag014 -
NDT
@NDTsocial
🧐 Selected from the June issue of NDT:
The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria
🔓doi.org/10.1093/ndt/gfaf232 -
NDT
@NDTsocial
🎥Watch Dr Eleonora Riccio present the NDT publication:
Dual GIP/GLP-1 Ra reduces residual proteinuria in non-diabetic Fabry Disease
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b728dc8… -
NDT
@NDTsocial
🧐Editor's choice from June issue NDT:
Biology of drug-induced acute nephrotoxicity: focus on the tubulointerstitium
🆓doi.org/10.1093/ndt/gfaf266 -
NDT
@NDTsocial
Renal gluconeogenesis:
a key metabolic hub in health and kidney disease
🔓doi.org/10.1093/ndt/gfag092 -
NDT
@NDTsocial
😍Check out the new June issue of NDT!
academic.oup.com/ndt/issue/41/6 -
NDT
@NDTsocial
Efficacy and safety of the cystic fibrosis transmembrane conductance regulator inhibitor GLPG2737 for autosomal dominant polycystic kidney disease: phase 2a MANGROVE study
doi.org/10.1093/ndt/gfag093 -
NDT
@NDTsocial
Post-AKI follow-up practices in France, Belgium and Marocco
doi.org/10.1093/ndt/gfag120 -
NDT
@NDTsocial
Protocadherin 7 -positive membranous nephropathy in China
doi.org/10.1093/ndt/gfag121 -
NDT
@NDTsocial
📹Watch Dr Ryunosuke Mitsuno present the NDT publication:
Parkinson disease imposes risk of kidney function decline
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f39bab2… -
NDT
@NDTsocial
🆕 Review:
Infection risk mitigation with complement inhibitors in kidney disease
doi.org/10.1093/ndt/gfag113 -
NDT
@NDTsocial
Kidney biopsy during pregnancy: indications, complications, results and therapeutic impact
doi.org/10.1093/ndt/gfag108 -
NDT
@NDTsocial
ATTR: the forgotten kidney amyloidosis
doi.org/10.1093/ndt/gfag118 -
NDT
@NDTsocial
Watch Dr Pasquale Esposito present the NDT publication:
Is Sex by Age Interaction the Missing Factor in Acute Kidney Injury Epidemiology?
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=76142d1…
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=76142d1… -
NDT
@NDTsocial
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD
🔓doi.org/10.1093/ndt/gfaf151 -
NDT
@NDTsocial
🎦Watch Dr Yujiro Maeoka present the NDT publication:
Effect of Haemodiafiltration Versus Haemodialysis on Vascular Access Patency when starting Hemodialysis
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=6a5be09… -
NDT
@NDTsocial
How to interpret the number needed to treat for clinicians
🔓doi.org/10.1093/ndt/gfaf168 -
NDT
@NDTsocial
New kidneys, old risks: cardiovascular challenges after transplantation
🔓doi.org/10.1093/ndt/gfaf239 -
NDT
@NDTsocial
🎦Watch this interesting author video with the NDT publication:
Genotype-Phenotype Correlations and Clinical Outcomes of Genetic TRPC6 Podocytopathies
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=20ae2d0… -
NDT
@NDTsocial
Anti-obinutuzumab antibodies in primary membranous nephropathy
doi.org/10.1093/ndt/gfag104 -
NDT
@NDTsocial
🤩The 2025 publications from the ERA bodies all in one place:
academic.oup.com/era/pages/registry-anniversary
🧐Selected for you:
KDIGO 2025 ADPKD guideline: a commentary on diagnosis and management of hepatopancreatic manifestations by the ERA Working Group Genes & Kidney
🆓doi.org/10.1093/ndt/gfaf159 -
NDT
@NDTsocial
📹Watch Dr Eleonora Riccio present the NDT publication:
Dual GIP/GLP-1 Ra reduces residual proteinuria in non-diabetic Fabry Disease
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b728dc8… -
NDT
@NDTsocial
Albuminuria drives hyperlipidemia in patients with Alport syndrome
🔓doi.org/10.1093/ndt/gfag100 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Urinary sediment predicts active proliferative glomerular diseases
More info: academic.oup.com/ndt/article-abstract/41/4/766/8276725
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Anti-PLA2R antibodies promote endothelial pyroptosis and a procoagulant phenotype through FcγRI signaling
doi.org/10.1093/ndt/gfag109 -
NDT
@NDTsocial
🧐Coffee consumption and chronic kidney disease
doi.org/10.1093/ndt/gfag107
☕️Current evidence suggests that moderate caffeine intake is probably safe in CKD and may be potentially beneficial -
NDT
@NDTsocial
Measuring the impact of tolvaptan-induced polyuria on quality of life in patients with autosomal dominant polycystic kidney disease
doi.org/10.1093/ndt/gfag102 -
NDT
@NDTsocial
🤒Clinical course up to 20 years after hantavirus infection
doi.org/10.1093/ndt/gfaf212
📹Also check out the accompanying author video:
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=a2fe7cb… -
NDT reposted
Ahmed Bennis MD 🫀
@drbennisahmed
Simple intervention. Big impact on patient choice. 🩺
New in NDT 2026 | Jifang Lu et al.
“Preemptive assessment of self-care ability increases choice for peritoneal dialysis in patients with kidney failure”
263 patients with kidney failure randomized to:
🔵 Control (n=133): KRT-directed education only
🔴 Intervention (n=130): KRT education + preemptive self-care PD ability evaluation
Primary outcome — PD choice:
• Control: 38.3%
• Intervention: 54.6%
That’s a 16-point jump in PD uptake just from telling patients upfront whether they can do it independently or would need assisted PD.
Factors independently associated with increased PD choice:
✅ Preemptive self-care PD ability evaluation
✅ Prior KRT knowledge
✅ Higher education level
The takeaway: patients don’t avoid PD because they can’t do it — they avoid it because nobody told them they could.
Informed choice starts with informed assessment. 💡
@NDTSocial
#nephrology #peritonealdialysis #kidneyfailure #ckd #shareddecisionmaking #medtwitter -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Strategies to improve life participation in children with CKD: A SONG report
🧐Personalized life priorities, minimizing treatment burden, facilitating access to opportunities and strengthening wellbeing.
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag099/8675035 -
NDT
@NDTsocial
Comparative Analysis of Lupus Nephritis Guidelines:
ACR 2025, EULAR 2025, and KDIGO 2024
🆓doi.org/10.1093/ndt/gfag106
@goKDIGO @ERAkidney -
NDT
@NDTsocial
🎥Watch Dr Jenny Wrackefeldt present the NDT publication:
The evolution of symptom burden in older men and women with advanced CKD
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=ae1577a… -
NDT
@NDTsocial
Medical device regulation and dialysis practice—impact on patients, doctors and manufacturers
doi.org/10.1093/ndt/gfaf269 -
NDT
@NDTsocial
Lanthanum carbonate does not reduce urinary oxalate excretion in hyperoxaluric kidney stone formers
doi.org/10.1093/ndt/gfag103 -
NDT
@NDTsocial
🎦Watch Dr Junhua Li present the NDT publication:
Efficacy and Safety of Belimumab in IgA Nephropathy Real World Evidence
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=62f8809… -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Practice patterns and outcomes in cancer patients developing immune checkpoint inhibitors–related AKI
More info: academic.oup.com/ndt/article/41/4/657/8261486
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
Ryu
@Ryu04196650Ryu
Diffuse foot process effacement in IgA nephropathy: MCD-Like versus non-MCD-like phenotypes and response to corticosteroid-based immunosuppression
@NDTsocial (2026)
MCD-IgANとDFPE-IgANの比較 MCD-IgANはステロイド治療に感受性
academic.oup.com/ndt/advance-article-abstract/doi/10.1093… -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Prevalence of Strongyloides stercoralis in haemodialysis patients in Vienna
More info: academic.oup.com/ndt/article/41/4/669/8266535
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Oral versus injectable GLP-1 receptor agonists in clinical practice!
🆓doi.org/10.1093/ndt/gfag101
📸Comparison of advantages of oral versus injectable glucagon like peptide 1 receptor agonists -
NDT
@NDTsocial
🎦Watch Dr Francesco Pesce present the NDT publication:
Bayesian Methods in Nephrology:
Applications in Adaptive Trials, Dynamic Risk Prediction, Pharmacokinetics, and Causal Inference
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=0c0b22d… -
NDT
@NDTsocial
Obesity as a modifiable risk factor in patients with chronic kidney disease
🆓doi.org/10.1093/ndt/gfaf231 -
NDT
@NDTsocial
🎥Watch Dr Diego Moriconi present the NDT publication:
RAAS blockade in the kidney Life-Cycle - Treatment Standard
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=85e30c9… -
NDT
@NDTsocial
KDM1A regulates nephron progenitor programs and is associated with human kidney disease risk
🔓doi.org/10.1093/ndt/gfag073 -
NDT
@NDTsocial
🤩Aim to become a leading Reviewer for the ERA journals, earn a place in the Reviewer Champions Gallery, and enjoy a complimentary ERA Congress registration!
www.era-online.org/reviewer-champions-gallery/ -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Recombinant alpha-1 microglobulin to improve outcomes in survivors of AKI
More info: academic.oup.com/ndt/article-abstract/41/4/649/8266817
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
KDIGO 2025 Clinical Practice Guideline for ADPKD:
a commentary on intracranial aneurysms and other vascular manifestations from the ERA Working Group Genes & Kidney
🔓doi.org/10.1093/ndt/gfag096
@ERAkidney -
NDT
@NDTsocial
🎥Watch Dr Patrick Mark present the NDT publication:
The updated global burden of chronic kidney disease: one death every 20 seconds
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=098a558… -
NDT
@NDTsocial
Complement activation in kidney transplantation
🆓doi.org/10.1093/ndt/gfaf206 -
NDT
@NDTsocial
🥳Check out the new May issue of NDT:
academic.oup.com/ndt/issue/41/5 -
NDT
@NDTsocial
What are the right endpoints to assess the effectiveness of new treatments for IgAN?
🆓doi.org/10.1093/ndt/gfaf184 -
NDT
@NDTsocial
Life support in hemodialysis emergencies—treatment standard
doi.org/10.1093/ndt/gfaf136 -
NDT
@NDTsocial
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction
🆓doi.org/10.1093/ndt/gfae019 -
NDT
@NDTsocial
🎦Watch Dr Wendy Mccallum present the NDT publication:
Acute Declines in Kidney Function with Thiazide Plus Loop Diuretics vs Loop Diuretics Alone in Acute Decompensated Heart Failure
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=5989aee… -
NDT
@NDTsocial
Recommendations for Pre-Analytical Urine Sample Handling To Allow Optimal Assessment of Albuminuria and Proteinuria
A consensus report of the USA NKF Albuminuria – Proteinuria Workshop
🔓doi.org/10.1093/ndt/gfag083 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Bayesian Methods in Nephrology (Adaptive Trials, Dynamic Risk Prediction, Pharmacokinetics, and Causal Inference)
🧐Bayesian approaches enhance the interpretability of complex data+ enable individualized clinical strategies.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Hierarchical composite endpoints for CKD trials
🆓doi.org/10.1093/ndt/gfag094 -
NDT
@NDTsocial
How should we target and reduce the production of pathogenic IgA in IgAN?
🆓doi.org/10.1093/ndt/gfaf185 -
NDT
@NDTsocial
🎥Watch Dr Aglaia Chalkia present the NDT publication:
Extrarenal Disease in ANCA-Associated Vasculitis:
Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=4dd8002… -
NDT
@NDTsocial
Estimated Glomerular Filtration Rate Slope and Kidney Outcomes in IgA Nephropathy
doi.org/10.1093/ndt/gfag089 -
NDT
@NDTsocial
Modeling Podocytopathies with Kidney Organoids
doi.org/10.1093/ndt/gfag091 -
NDT
@NDTsocial
RAAS blockade in the kidney Life-Cycle: Treatment Standard
doi.org/10.1093/ndt/gfag090 -
NDT
@NDTsocial
Immune checkpoint inhibitor–associated nephritis—treatment standard
🆓doi.org/10.1093/ndt/gfae184 -
NDT
@NDTsocial
🎥Watch Dr Li-Jie He present the NDT publication:
Diabetes Mellitus Attenuates Response to Anti-CD20 Therapy in Primary Membranous Nephropathy Despite Equivalent b-Cell Depletion
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=4da1f89… -
NDT
@NDTsocial
GLP-1-based therapeutics for cardiorenal protection in metabolic diseases
🔓doi.org/10.1093/ndt/gfaf110 -
NDT
@NDTsocial
Admission kidney tubule biomarkers do not predict acute kidney injury or in-hospital adverse events in acute heart failure
🔓doi.org/10.1093/ndt/gfag079 -
NDT
@NDTsocial
Parkinson Disease imposes risk of kidney function decline
🔓doi.org/10.1093/ndt/gfag086 -
NDT
@NDTsocial
Management of adult patients with podocytopathies:
an update from the ERA Immunonephrology Working Group
🆓doi.org/10.1093/ndt/gfae025
@ERAkidney -
NDT
@NDTsocial
Pregnancies in living kidney donors
🔓doi.org/10.1093/ndt/gfag080 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Hyperkalemia treatment standard
More info: academic.oup.com/ndt/article/39/7/1097/7616929?searchresu…
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillation
More info: academic.oup.com/ndt/article/39/8/1248/7685545?searchresu…
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Optimal glucocorticoid therapy in lupus nephritis
doi.org/10.1093/ndt/gfae294 -
NDT
@NDTsocial
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index
doi.org/10.1093/ndt/gfaf197 -
NDT
@NDTsocial
Torque Teno virus load is predictive for malignancies in kidney transplant recipients
doi.org/10.1093/ndt/gfag078 -
NDT
@NDTsocial
🎥Watch Dr Aglaia Chalkia present the NDT publication:
Extrarenal disease in ANCA-associated vasculitis:
challenges and evolving therapeutic strategies on behalf of the Immunonephrology Working Group ( IWG ) of the ERA
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=4dd8002…
@ERAkidney -
NDT
@NDTsocial
The effect of GLP-1 receptor agonists on renal outcomes: a systematic review and meta-analysis
doi.org/10.1093/ndt/gfaf193 -
NDT
@NDTsocial
QT-prolonging medications:
prevalence of use and associated risks in CKD
🔓doi.org/10.1093/ndt/gfaf196 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Membranous nephropathy treatment standard
More info: academic.oup.com/ndt/article/39/3/403/7338278?searchresult=1
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Beautiful and effective:
what art can do for nephrologists and for our patients
🆓doi.org/10.1093/ndt/gfad228 -
NDT
@NDTsocial
🤩Check out the new April issue of NDT!
📖academic.oup.com/ndt/issue/41/4
👌Editor's choice:
ERA’s ABCDE framework for kidney disease prevention: turning the WHO kidney health resolution into action
🆓doi.org/10.1093/ndt/gfaf198 -
NDT
@NDTsocial
Novel protein biomarkers for risk stratification and personalized medicine
🔓doi.org/10.1093/ndt/gfag068 -
NDT
@NDTsocial
Association of UACR and UPCR with kidney failure: analysis of observational data in patients with rare kidney diseases
doi.org/10.1093/ndt/gfag066 -
NDT
@NDTsocial
Better cardiorenal protection for patients with CKD and type 1 diabetes
🆓doi.org/10.1093/ndt/gfag076 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Later braker at the #wcn2026 and open access at @NDTsocial
Sexual Dimorphism and Age Effects in CKD and T2DM (CONFIDENCE Trial)
🧐Although UACR response of FIN/EMPA was age + sex-dependent, benefit of combination therapy was independent.
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfag075/8551333 -
NDT
@NDTsocial
Deciphering the genetic basis of electrolyte homeostasis:
genome-wide association studies of plasma sodium, chloride, and potassium in two European cohorts
doi.org/10.1093/ndt/gfag069 -
NDT
@NDTsocial
🧐NEW pro/con:
👍Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? Yes
🆓doi.org/10.1093/ndt/gfag072
👎Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? No
🆓doi.org/10.1093/ndt/gfag071 -
NDT reposted
Gunnar Henrik Heine
@gunnar_heine
Of mice and men:
Indexing for Body Surface Area when Assessing Kidney Function academic.oup.com/ndt/article/doi/10.1093/ndt/gfag063/8530518
@hjanders_hans @NDTsocial -
NDT
@NDTsocial
Measuring urine albumin and total protein
🔓doi.org/10.1093/ndt/gfag060 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Light-chain (AL) amyloidosis for nephrologists—treatment standard
More info: academic.oup.com/ndt/article/40/1/34/7815202?searchresult=1
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
ERA - European Renal Association
@ERAkidney
🧵 1/9
As Nephrology Dialysis Transplantation @NDTsocial celebrates 40 years 🎉, a new editorial ✨ highlights how biological sex shapes CV benefits of exercise in CKD.
@VanAmaryllis @olgabalafa @anagarcp #wera
Read the full article at 🔗academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfag…
Read the thread for a sneak peek 👇👇 👇 -
NDT
@NDTsocial
Children born to mothers receiving chronic dialysis, a national French cohort (2013-2021)
doi.org/10.1093/ndt/gfag029 -
NDT
@NDTsocial
Is sex by age interaction the missing factor in acute kidney injury epidemiology?
doi.org/10.1093/ndt/gfag064 -
NDT
@NDTsocial
🥳NDT celebrates its 40th anniversary this year!
👏Thank you to our author community for 4 decades of outstanding research!
🤩Be part of our future and publish with NDT:
academic.oup.com/ndt/pages/why-publish
@ERAkidney @hjanders_hans
🎉Discover our anniversary design in 2026👇 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Anti-glomerular basement membrane disease—treatment standard
More info: academic.oup.com/ndt/article/41/1/42/8257581?searchresult=1
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Acute post-streptococcal glomerulonephritis in children—treatment standard
More info: academic.oup.com/ndt/article/40/10/1843/8197890?searchres…
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
YNP of ERA
@ynptweets
👉🏻 Check out this month snapshot summary about CAKUT disease in adult patients
doi.org/10.1093/ndt/gfaf172
✍️Charlotte Hammett is the YNP author
Post prepared by @jt_nephrology
@NDTsocial
@ERAkidney -
NDT
@NDTsocial
Genetic kidney disease in adults – the pathologists’ perspective
doi.org/10.1093/ndt/gfag047 -
NDT
@NDTsocial
The evolution of symptom burden in older men and women with advanced CKD
doi.org/10.1093/ndt/gfag045 -
NDT
@NDTsocial
Global epidemiology of kidney cancer
doi.org/10.1093/ndt/gfae036
➡️The authors aim to facilitate a more nuanced understanding of KC's epidemiology and determinants providing valuable insights for researchers, clinicians and policymakers alike -
NDT
@NDTsocial
Urinary Albumin-to-Creatinine Associates More Closely than Protein-to-Creatinine Ratio with Kidney Outcomes in Pediatric Chronic Kidney Disease
🔓doi.org/10.1093/ndt/gfag061 -
NDT
@NDTsocial
🎥Watch Dr Ina Ystroem present the NDT publication:
IgA nephropathy occurrence, treatment, and prognosis in the last two decades in Denmark
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=feebcd8… -
NDT
@NDTsocial
🎥Watch Dr Lucia Del Vecchio present the NDT publication:
Trends in nephrology:
from Manels to a balanced representation of all community members
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=2bca85c… -
NDT
@NDTsocial
Clinical impact of ionized calcium and hidden hypocalcemia on cardiovascular outcomes in dialysis patients
🔓doi.org/10.1093/ndt/gfag057 -
NDT reposted
Rafael López Márquez
@RafaelLpezMrqu2
🤔Can urinary dipstick findings predict UTI risk in patients receiving canagliflozin?
🙅♂️HRs for canagliflozin vs placebo were 0.94 (0.73–1.21) in
the LE-abnormal group, and 0.92 (0.59–1.43) in NIT-abnormal group
⚠️post hoc CANVAS and CREDENCE trials
📄 via @NDTsocial -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Kidney disease after hematopoietic stem cell transplant—treatment standard
More info: academic.oup.com/ndt/article/40/12/2268/8205567?searchres…
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Life support in hemodialysis emergencies—treatment standard
More info: academic.oup.com/ndt/article/40/11/2046/8202812?searchres…
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
🎦Watch Dr Milica Bozic present the NDT publication:
N-methyl-D-aspartate receptor inhibition protects against obesity-induced kidney disease
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=ee13386… -
NDT
@NDTsocial
Urinary albumin-to-creatinine associates more closely than protein-to-creatinine ratio with kidney outcomes in pediatric chronic kidney disease
🔓doi.org/10.1093/ndt/gfag061 -
NDT
@NDTsocial
🎥Watch Dr Claudio Ronco present the NDT publication:
Hemoadsorption Combined with Hemodialysis (HAHD):
a Consensus Statement from an International Expert Panel
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=7d5e155… -
NDT
@NDTsocial
Clinical phenotype and prognosis of patients with diabetic kidney disease complicated by a primary podocytopathy
doi.org/10.1093/ndt/gfag050 -
NDT
@NDTsocial
QT-prolonging medications: prevalence of use and associated risks in CKD
doi.org/10.1093/ndt/gfaf196 -
NDT
@NDTsocial
Chronic kidney disease G3–5 in lupus nephritis—
prevalence, progression, and risk factors
doi.org/10.1093/ndt/gfaf201 -
NDT
@NDTsocial
Renal blood flow and progression to kidney failure in ADPKD
doi.org/10.1093/ndt/gfag059 -
NDT
@NDTsocial
2025
AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults:
A Commentary from the European Renal Best Practice (ERBP)
🔓doi.org/10.1093/ndt/gfag055 -
NDT
@NDTsocial
🥳Apply now to become a 2026-2027 NDT Editorial Fellow!
🧐Editorial Fellows work hand-in-hand with one of the NDT Associate Editors and are involved in all aspects of the editorial process
For more info, just go to 👇👇👇
academic.oup.com/ndt/pages/editorial-fellowship-call -
NDT
@NDTsocial
Sepsis-associated acute kidney injury—treatment standard
doi.org/10.1093/ndt/gfad142 -
NDT
@NDTsocial
Exome sequencing in patients with medullary sponge kidney
doi.org/10.1093/ndt/gfag043 -
NDT
@NDTsocial
The European distal renal tubular acidosis registry: a five-year analysis
doi.org/10.1093/ndt/gfag051 -
NDT
@NDTsocial
📢NEW Review:
Determining baseline serum creatinine in harmonized criteria for kidney disease: unfinished business
doi.org/10.1093/ndt/gfag052 -
NDT
@NDTsocial
Kidney health during critical illness or upon major surgery
🆓doi.org/10.1093/ndt/gfag026 -
NDT
@NDTsocial
IGFBP-5/TGF-β1 mediated crosstalk between endothelial and tubular epithelial cells promotes
interstitial fibrosis
doi.org/10.1093/ndt/gfaf179 -
NDT
@NDTsocial
Low dose IL-2 administration prevents but fails to treat experimental autoimmune anti-myeloperoxidase glomerulonephritis
doi.org/10.1093/ndt/gfaf178 -
NDT
@NDTsocial
Predicting mortality and short-term outcomes of continuous kidney replacement therapies in neonates and infants
doi.org/10.1093/ndt/gfaf173
➡️The authors propose the XGBoost models for identifying factors associated with short-term outcomes of CKRT in neonates and infants -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🧬IgA Nephropathy: practical management pathway
Start with Urinalysis, UPCR & eGFR→ decide kidney biopsy🔬
-Low risk→ supportive care (RASi, BP control) 💊
-High risk lesions or persistent proteinuria →steroids/immunosuppression
🔗doi.org/10.1093/ndt/gfaf247 🆕
#igan -
NDT reposted
S.E.N. Nefrología
@SENefrologia
📰 NUEVA publicación en @NDTsocial @ERAkidney |🫘 "The updated global burden of chronic kidney disease: one death every 20 seconds"
🌍 850 million people with kidney disease globally
🇪🇺 93.1 million adults in Europe
📖 Acceso abierto: academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfag…
✍️ @aortznfr, @torra_roser, Jennifer S Lees, Vianda S Stel, Anneke Kramer, Patrick B Mark -
NDT
@NDTsocial
📹Watch Dr Pierre Delanaye present the NDT publication:
Diabetic status and the performances of creatinine- and cystatin C-based eGFR equations
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f500677… -
NDT
@NDTsocial
A consensus statement on the management of vertebral fractures in CKD stages G4–G5D
🆓doi.org/10.1093/ndt/gfaf256 -
NDT
@NDTsocial
😍Call for NDT Cover Images!
🤩If you have an eye-catching image focused on kidney disease, please email it to the NDT Editorial Office, and it might appear on one of the next covers of NDT!
academic.oup.com/ndt/pages/call-for-images -
NDT
@NDTsocial
How to interpret the number needed to treat for clinicians
🔓doi.org/10.1093/ndt/gfaf168
@EraRegistry -
NDT
@NDTsocial
Hemoadsorption Combined with Hemodialysis (HAHD):
a Consensus Statement from an International Expert Panel
🔓doi.org/10.1093/ndt/gfag046 -
NDT
@NDTsocial
🎥Watch Dr Guizhen Yu present the NDT publication:
Albuminuria and kidney disease progression in IgA nephropathy in China
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=67f5df2… -
NDT
@NDTsocial
How should we best manage the consequences of nephron loss in IgAN?
🆓doi.org/10.1093/ndt/gfaf225 -
NDT
@NDTsocial
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications
🆓doi.org/10.1093/ndt/gfaf156 -
NDT
@NDTsocial
😩The updated global burden of chronic kidney disease:
one death every 20 seconds
🆓doi.org/10.1093/ndt/gfag040
@ERAkidney @OxfordJournals -
NDT
@NDTsocial
🤩 Check out the new March issue of NDT!
academic.oup.com/ndt/issue/41/3 -
NDT
@NDTsocial
🎥Watch Dr Nuttha Lumlertgul present the NDT publication:
Diagnosis, diagnostic approach and challenges in pregnancy-associated AKI - The ADQI 32 consensus meeting
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c30159d… -
NDT
@NDTsocial
🤩Check out our new Supplement on 'The Treatment Paradigm in IgAN Globally'
academic.oup.com/ndt/issue/41/Supplement_1
🧐Selected for you:
How should we approach the treatment of IgAN in 2025?
doi.org/10.1093/ndt/gfaf223
#openaccess -
NDT reposted
Kenar Jhaveri
@kdjhaveri
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfag… Trends in nephrology: the evolution and maturation of onconephrology @onconephsociety @ArashRashidi14 @NDTsocial
-
NDT
@NDTsocial
🆕 Review:
Effects of microplastics and nanoplastics on the kidneys
🆓doi.org/10.1093/ndt/gfag034 -
NDT
@NDTsocial
Therapeutic opportunities for CKD-associated osteoporosis in adults with kidney failure imply screening
doi.org/10.1093/ndt/gfag038 -
NDT
@NDTsocial
👌NEW publication from the Women of ERA (WERA) Task Force:
Trends in nephrology:
from manels to a balanced representation of all community members
🆓doi.org/10.1093/ndt/gfag044
@ERAkidney -
NDT
@NDTsocial
Novel immune-related susceptibility loci associated with pediatric steroid-sensitive nephrotic syndrome identified by a transethnic genome-wide association study
🆓doi.org/10.1093/ndt/gfag041 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🫘 #ckd → Heart via Extracellular Vesicles #ev 🚀
⬆️ EVs carry 🧬 miRNA/proteins
➡️ 🧫 Endothelial dysfunction
➡️ 🧱 Fibrosis & calcification
➡️ ❤️ Remodeling
🔗 doi.org/10.1093/ndt/gfag022
#nephrology #ckd #cvd -
NDT
@NDTsocial
Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial
🆓doi.org/10.1093/ndt/gfag036 -
NDT
@NDTsocial
🎦Watch Dr Faed Husain-Syed present the NDT publication:
Pulsed ultrasound activation of neural reflexes: a therapeutic strategy against AKI and inflammation
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f03805b… -
NDT
@NDTsocial
🎦Watch Dr Rashidi Arash present the NDT publication:
Trends in nephrology:
The Evolution and Maturation of Onconephrology
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=76011c1… -
NDT
@NDTsocial
Sex differences in the development of CKD complications
doi.org/10.1093/ndt/gfag035 -
NDT
@NDTsocial
NEW Editorial:
Disconnected universes:
Advanced kidney research versus absence of basic kidney care in high income countries
🆓doi.org/10.1093/ndt/gfag039 -
NDT
@NDTsocial
🆕 Review:
Finerenone with Empagliflozin in CKD with diabetes (CONFIDENCE): Only a blood pressure effect? Likely!
doi.org/10.1093/ndt/gfag042 -
NDT
@NDTsocial
Creatinine, cystatin C or both to estimate glomerular filtration rate in kidney transplant recipients?
doi.org/10.1093/ndt/gfag037 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Kidney transplantation in Africa – workforce, capabilities, and perceived barriers
🧐Resource limitations continue to restrict access to KT in Africa. More government support (funding and policy development) is needed.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Acute post-streptococcal glomerulonephritis in children— treatment standard
doi.org/10.1093/ndt/gfaf130 -
NDT
@NDTsocial
Treatment standard: CKD in the geriatric patient
doi.org/10.1093/ndt/gfaf115 -
NDT
@NDTsocial
Bone turnover markers in the management of CKD-associated osteoporosis – a European consensus
doi.org/10.1093/ndt/gfag033 -
NDT
@NDTsocial
🆕 Editorial:
Albuminuria or proteinuria in glomerular disease and CKD – which one to use?
🆓 doi.org/10.1093/ndt/gfag020 -
NDT
@NDTsocial
🎦Watch Dr Jialin Han present the NDT publication:
Are patients with primary glomerular disease at increased risk of malignancy?
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=6431c6c… -
NDT
@NDTsocial
Combination therapy:
an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease
🆓doi.org/10.1093/ndt/gfae212 -
NDT
@NDTsocial
Early eculizumab treatment improves renal outcomes in pediatric lupus nephritis with thrombotic microangiopathy
doi.org/10.1093/ndt/gfag031 -
NDT
@NDTsocial
🎦Watch Dr Mariana Murea present the NDT publication:
Meta-analyses overgeneralize SGLT2 inhibitor effectiveness in populations with low albuminuria, no diabetes, no heart failure and no atherovascular heart disease
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=379c15b… -
NDT
@NDTsocial
N-methyl-D-aspartate receptor inhibition protects against obesity-induced kidney disease
🔓doi.org/10.1093/ndt/gfag027 -
NDT
@NDTsocial
Renal and urothelial cancer risks with SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes: a target trial emulation
doi.org/10.1093/ndt/gfag028 -
NDT
@NDTsocial
Renal functional reserve predicts GFR response to empagliflozin in RENALIS and RACELINES clinical trials
🆓doi.org/10.1093/ndt/gfag025 -
NDT
@NDTsocial
Nephrotoxicity and kidney outcomes in pediatric oncology patients
doi.org/10.1093/ndt/gfaf169 -
NDT
@NDTsocial
Changing from the CKD-EPI to the EKFC creatinine equation to estimate glomerular filtration rate in adults in a Northern European health system
🔓doi.org/10.1093/ndt/gfaf148 -
NDT
@NDTsocial
Management of Antithrombotic Therapies in Kidney Transplantation Candidates and Recipients:
An ERBP Clinical Practice Document by the Descartes Working Group of the ERA and the EKITA Committee of ESOT
🆓doi.org/10.1093/ndt/gfag024
@ERAkidney @ESOTtransplant -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Over 500,000 pts on kidney replacement therapy in the EU
🧐The EU must be aware of this when designing the Accelerating Clinical Trials-EU (ACT EU), EU Medical Device Regulation (MDR) or when defining healthcare priorities.
▶️ academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
What is peptide receptor radionuclide therapy (PRRT) and how is it related to nephrology? 🤔
@NDTsocial @hjanders_hans
@ERAkidney
🧵by @smirioglu
doi.org/10.1093/ndt/gfaf121Post not available here, view on X
NDT
@NDTsocial
Do we have protective strategies to reduce kidney damage?
NDT
@NDTsocial
Check @NDTsocial for more content from the Journal!
-
NDT
@NDTsocial
🎥Watch Dr Kengo Kidokoro present the NDT publication:
The nonsteroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=4707cc1… -
NDT
@NDTsocial
Light-chain (AL) amyloidosis for nephrologists —treatment standard
doi.org/10.1093/ndt/gfae224 -
NDT
@NDTsocial
Membranous nephropathy treatment standard
🆓doi.org/10.1093/ndt/gfad225 -
NDT
@NDTsocial
Single-nephron eGFR and kidney function decline in IgA nephropathy
doi.org/10.1093/ndt/gfag019 -
NDT reposted
Noroژa | Niloufar Ebrahimi
@n0r0zha
The February issue of NDT is out!
Packed with insightful research and fresh perspectives in nephrology.✨
Enjoy!
@NDTsocial
academic.oup.com/ndt/issue/41/2 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure
More info: academic.oup.com/ndt/article-abstract/41/1/31/8185937
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Chronic lung diseases and kidney disease: pathophysiology and management
More info: academic.oup.com/ndt/article/41/1/20/8122104
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
SGLT2 inhibitors and acute kidney injury
🆓doi.org/10.1093/ndt/gfaf132 -
NDT
@NDTsocial
Global, regional, and national burden of CKD in children and adolescents
📖doi.org/10.1093/ndt/gfag018 -
NDT
@NDTsocial
🎥Watch Dr Sepideh Mahboobishoorjeh present the NDT publication:
Effects of dietary interventions for metabolic acidosis in chronic kidney disease: a systematic review and meta-analysis
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=77a9038… -
NDT
@NDTsocial
Clinical applications of artificial intelligence in autosomal dominant polycystic kidney disease
doi.org/10.1093/ndt/gfag010 -
NDT
@NDTsocial
🎦Watch Dr Alexandre Andrade present the NDT publication:
Cognitive impairment in chronic kidney disease: Role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=52c406e… -
NDT
@NDTsocial
Aldosterone synthase inhibitors for uncontrolled and resistant hypertension in CKD: an assessment from bench to bedside
doi.org/10.1093/ndt/gfag013 -
NDT
@NDTsocial
🆕 Editorial:
Oil supplementation and cardiovascular mortality in the dialysis population
🆓 doi.org/10.1093/ndt/gfag015 -
NDT
@NDTsocial
🎥Watch Dr Vladimir Dobronravov present the NDT publication:
Tonsillectomy and immunosuppression improve outcomes in Caucasians with high-risk IgA-nephropathy
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=2d941fa… -
NDT
@NDTsocial
A website calculator to benchmark the carbon footprint of haemodialysis
doi.org/10.1093/ndt/gfaf263 -
NDT
@NDTsocial
📹Watch Dr Raphael Duivenvoorden present the NDT publication:
Urinary carbonic anhydrase 1 as a marker of hematuria in IgA nephropathy patients
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b896a09… -
NDT
@NDTsocial
🧐Check out two new 'Trends in Nephrology' publications in NDT:
👉The Evolution and Maturation of Onconephrology
doi.org/10.1093/ndt/gfag012
👉From nihilism to targeted treatment of antibody-mediated rejection
doi.org/10.1093/ndt/gfag011 -
NDT
@NDTsocial
📢NEW Review:
Drug stewardship for RAS-inhibitors and SGLT2-inhibitors in chronic kidney disease: stay on, restart
doi.org/10.1093/ndt/gfag008 -
NDT
@NDTsocial
🆕Association between body roundness index and all-cause and cardiovascular disease mortality in maintenance hemodialysis patients:
👉evidence from a prospective cohort study in Southern China
📖doi.org/10.1093/ndt/gfag006 -
NDT
@NDTsocial
🎥Watch Dr Nuttha Lumlertgul present the NDT publication:
Diagnosis, diagnostic approach and challenges in pregnancy-associated AKI:
The ADQI 32 consensus meeting
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c30159d… -
NDT
@NDTsocial
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
doi.org/10.1093/ndt/gfaf127 -
NDT
@NDTsocial
Genome-wide donor–recipient non-HLA mismatch and graft loss
🆓doi.org/10.1093/ndt/gfaf073 -
NDT
@NDTsocial
🎥Watch Dr Nafees Sathik present the NDT publication:
International Pediactric Nephrology Association IgA Nephropathy Guidelines - A commentary
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=8451fa7… -
NDT
@NDTsocial
Trends in nephrology:
from “supportive care” to CKD combination therapy
doi.org/10.1093/ndt/gfag003 -
NDT
@NDTsocial
📹Watch Dr Paul Hanna present the NDT publication:
Nephrotoxicity of conventional chemotherapeutics:
Part II- non-platinum agents and miscellaneous nephrotoxic drugs
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=28ffd21… -
NDT
@NDTsocial
😍Did you already discover the NDT kidney art gallery?
www.era-online.org/ndt-kidney-art-gallery/
🤩Check it out and send us one of your own kidney images! -
NDT
@NDTsocial
RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls
doi.org/10.1093/ndt/gfag002 -
NDT
@NDTsocial
Don’t think that combined liver kidney transplant can solve everything in primary hyperoxaluria type 1!
Read more here⬇️:
➡️doi.org/10.1093/ndt/gfag004 -
NDT
@NDTsocial
🎥Watch Dr Ana Carina Ferreira present the NDT publication:
Safeguarding innovation in dialysis - rethinking the EU Medical Device Regulation
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=8a16742… -
NDT
@NDTsocial
🎥Watch Dr Solos Jaturapisanukul present the NDT publication:
Management of Monoclonal Gammopathy of Renal Significance: Treatment Standard
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b01f0e3… -
NDT
@NDTsocial
🤩Editor's choice from the January issue of NDT:
academic.oup.com/ndt/issue/41/1
Anti-glomerular basement membrane disease —treatment standard
doi.org/10.1093/ndt/gfaf190 -
NDT
@NDTsocial
Telitacicept targets Gd-IgA1 & autoantibody-producing B cells in IgA nephropathy
doi.org/10.1093/ndt/gfag001
This work summarizes current progresses in targeting Gd-IgA1-producing cells for the treatment of IgAN with a focus on therapeutic strategies including BAFF/APRIL inhibitors -
NDT
@NDTsocial
🎥Watch Dr Heather Walker present the NDT publication:
The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks
⬇️⬇️⬇️
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=8300612… -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality
More info: academic.oup.com/ndt/article-abstract/40/11/2159/8152908
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Incidence and prevalence of kidney replacement therapy in Central and Eastern Europe – Trends from the ERA registry
doi.org/10.1093/ndt/gfaf268 -
NDT
@NDTsocial
ERA’s ABCDE Framework for Kidney Disease Prevention:
Turning the WHO Kidney Health Resolution into action
doi.org/10.1093/ndt/gfaf198 -
NDT reposted
Daniel Díaz - García
@DanielDiazNF
Intensive treatment for anti-GBM GN when there is:
▫️Clinically evident alveolar haemorrhage
▫️Rapidly progressive GN without immediate dialysis requirement
▫️RPGN requiring dialysis, if:
<100% glomerular crescents
<50% glomerulosclerosis
Non-oliguric
Double-positive ANCA -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Foam sclerotherapy for symptomatic cysts in ADPKD, ADPLD and solitary cysts
More info : academic.oup.com/ndt/article-abstract/40/11/2169/8178516
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
🎥Watch Dr Solos Jaturapisanukul present the NDT publication:
Management of monoclonal gammopathy of renal significance: treatment standards
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b01f0e3… -
NDT
@NDTsocial
🤩Check out the January issue of NDT!
academic.oup.com/ndt
👍Editor's choice:
Anti-glomerular basement membrane disease—treatment standard
doi.org/10.1093/ndt/gfaf190 -
NDT
@NDTsocial
Medical device regulation and dialysis practice – impact on patients, doctors and manufacturers
🆓doi.org/10.1093/ndt/gfaf269 -
NDT
@NDTsocial
Nephrotic syndrome in mice elevates FGF23 levels and leads to cardiac hypertrophy in the absence of hyperphosphatemia
doi.org/10.1093/ndt/gfaf272 -
NDT
@NDTsocial
Podocyte-specific translational profiling in vivo uncovers distinct patterns in Trpc6-deficient podocytes
doi.org/10.1093/ndt/gfaf267 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
The environmental and genetic architectures of ageing and CKD
More info: academic.oup.com/ndt/article/40/11/2008/8223400
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
Jasmine Sethi
@JasmineNephro
💊Steroid dosing in Lupus Nephritis
academic.oup.com/ndt/article/40/7/1284/7929884?login=false
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Safeguarding innovation in dialysis—rethinking the EU Medical Device Regulation
🆓doi.org/10.1093/ndt/gfaf270 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🩸Anemia in CKD Management
academic.oup.com/ndt/article/39/5/770/7452913?login=false
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Biology of drug-induced acute nephrotoxicity: focus on the tubulointerstitium
doi.org/10.1093/ndt/gfaf266 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Tonsillectomy and immunosuppression improve outcomes in Caucasians with high-risk IgAN
🧐IgAN progression in 3.5% after TE compared to 28.9% without TE (adjusted HR = 0.12 (0.03–0.42).
▶️ academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes
doi.org/10.1093/ndt/gfaf264 -
NDT
@NDTsocial
The effect of icodextrin on peritoneal dialysis patients with congestive heart failure:
a time-varying exposure design and target trial emulation approach
🆓doi.org/10.1093/ndt/gfaf265 -
NDT
@NDTsocial
🎥 Watch Dr Faed Husain-Syed present the NDT publication:
Pulsed ultrasound activation of neural reflexes:
a therapeutic strategy strategy against AKI and inflammation
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f03805b… -
NDT reposted
YNP of ERA
@ynptweets
🙌🏻 Check out this month snapshot summary about pharmacologial differences between man and woman with CKD
doi.org/10.1093/ndt/gfaf125
@SoleneLaville is the YNP author
Post prepared by @jt_nephrology
@ERAkidney @NDTsocial -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🔖Unexplained CKD (#ckdu) is often under-investigated, not truly unexplained
🩺Diagnostic algorithm for #ckdx cause—
integrating GFR(G1–5), albuminuria(A1–3), phenotype, family h/o, biopsy & genomics
🔗doi.org/10.1093/ndt/gfaf092
@ Halbritter J et al.
#genetics #nephrology #nephx -
NDT
@NDTsocial
IgA nephropathy in adults: treatment standard
doi.org/10.1093/ndt/gfad146 -
NDT
@NDTsocial
🎥Watch Dr Faed Husain-Syed present the NDT publication:
Pulsed ultrasound activation of neural reflexes: a therapeutic strategy strategy against AKI and inflammation
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f03805b… -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
This month @NDTsocial issue, do you support the continued use of PEX in TMA or not?
academic.oup.com/ndt/article/40/12/2224/8225746
academic.oup.com/ndt/article/40/12/2227/8237447
@hjanders_hans -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
The @NDTsocial continue its magical #treatment_standard series, this time with treatment of kidney diseases following HSCT @hjanders_hans
academic.oup.com/ndt/article/40/12/2268/8205567 -
NDT
@NDTsocial
📣NEW Editorial:
High-cost glomerular disease drugs: eagerly anticipated with caveats
🆓doi.org/10.1093/ndt/gfaf261 -
NDT
@NDTsocial
📹Watch Dr Vincenzo Bellizzi present the NDT publication:
Cost-effectiveness of protein-restricted diets in advanced CKD
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=4f141fe… -
NDT
@NDTsocial
Effect of haemodialysis on the brain and heart assessed using multiparametric MRI
🆓doi.org/10.1093/ndt/gfaf117 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🫘Disease modification in IgA nephropathy(#igan)
True IgAN therapies must hit the disease drivers(immune mediated) , not just downstream fibrosis or hyperfiltration
🟩Green=IgAN-specific pathways
🟦Blue=generic CKD progression pathways
🔗doi.org/10.1093/ndt/gfaf259
@NDTsocial
#nephrology #medtwitter -
NDT
@NDTsocial
🎥Watch Vanessa Marchant present the NDT publication:
Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b897c59… -
NDT
@NDTsocial
Disease Modification in Immunoglobulin A Nephropathy
🆓 doi.org/10.1093/ndt/gfaf259 -
NDT
@NDTsocial
📹Watch Kengo Kidokoro present the NDT publication:
The nonsteroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=4707cc1… -
NDT
@NDTsocial
Anaemia in CKD: treatment standard
doi.org/10.1093/ndt/gfad250 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Management of MGRS: treatment standard
🧐Targeting for a deep hematologic response that is strongly associated with improved renal outcomes is the goal.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
🎥Watch Dr Paul Hanna present the NDT publication:
Nephrotoxicity of Conventional Chemotherapeutics: Part I - Platinum Compounds and Antimetabolite Agents
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=1290200… -
NDT
@NDTsocial
Immune checkpoint inhibitor–associated nephritis: treatment standard
doi.org/10.1093/ndt/gfae184 -
NDT
@NDTsocial
Cardiorenal outcomes of weight loss interventions in people with CKD and type 2 diabetes
doi.org/10.1093/ndt/gfaf258 -
NDT
@NDTsocial
SGLT2 inhibition for patients with ADPKD – closing the evidence gap
doi.org/10.1093/ndt/gfaf061 -
NDT
@NDTsocial
🎥Watch Dr Denise Mafra present the NDT publication:
Low-protein diet adherence and CKD progression during long-term follow-up
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c2d2533… -
NDT reposted
Jasmine Sethi
@JasmineNephro
🤩Management of Monoclonal Gammopathy of Renal Significance
💪Clone Directed therapy
academic.oup.com/ndt/advance-article-abstract/doi/10.1093…
@NDTsocial @hjanders_hans -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🔥HSCT → Kidney Injury is a cascade of endothelial damage, cytokine storms & complement overdrive
From GVHD ➡️ TMA ➡️ NETs ➡️ MAC formation — the kidney becomes a battlefield
🔗 doi.org/10.1093/ndt/gfaf139 🆕
#nephtwitter #onconephrology #hsct #tma #aki #ckd #medx -
NDT
@NDTsocial
🧐 Watch Dr Augusto Vaglio present the NDT publication:
Novel and traditional B-cell depleting agents for IgG4-related disease: a critical view
🎥👇🎥👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=312b391… -
NDT
@NDTsocial
A consensus statement on the management of vertebral fractures in CKD stages G4-G5D
🆓doi.org/10.1093/ndt/gfaf256
This paper discusses the management of skeletal fragility in CKD patients, from diagnosis to treatment, with a particular focus on vertebral fractures in CKD G4-G5D -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🧬 #kidney injury after #hsct is multifactorial—but a structured approach saves kidneys
From #aki ➡️ #tma ➡️ #gn ➡️ #ckd, early recognition + targeted therapy is everything
📊Excellent flowchart for clinicians managing post-HSCT renal complications
🔗doi.org/10.1093/ndt/gfaf139 🆕 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🫘 Renal amyloidosis is all about early identification + exact typing
✨Fat pad➡️ Kidney biopsy🔬➡️ IF/IHC/EM➡️ 🧬Proteomics
Rx starts with knowing the right amyloid
🔗 doi.org/10.1093/ndt/gfaf042 🆕
@NDTsocial for details
#amyloidosis #nephtwitter #nephrology -
NDT
@NDTsocial
Management of monoclonal gammopathy of renal significance: treatment standard
📖doi.org/10.1093/ndt/gfaf254 -
NDT
@NDTsocial
Efficacy and safety of dapagliflozin in inactive lupus nephritis: a randomized crossover trial
doi.org/10.1093/ndt/gfaf257 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🦀💉Immunecheck point inhibitor associated Nephrotoxicity
academic.oup.com/ndt/article/39/11/1785/7733108?login=false
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Is #rituximab (RTX) effective in fibrillary glomerulonephritis? 🤔
@NDTsocial @hjanders_hans
@ERAkidney
🧵by @smirioglu
doi.org/10.1093/ndt/gfaf109Post not available here, view on X
NDT
@NDTsocial
5 women and 12 men with a median age of 54 years were evaluated.
NDT
@NDTsocial
In group 1, 4 patients (36.4%) achieved an overall response (2 complete and 2 partial) and 7 patients failed to respond. ❌
Post not available here, view on X
NDT
@NDTsocial
Response rate with the intensive regimen was good but should be replicated in other studies! 👀
NDT
@NDTsocial
Check @NDTsocial for more content from the Journal!
-
NDT
@NDTsocial
C3G and Ig-MPGN—treatment standard
doi.org/10.1093/ndt/gfad182 -
NDT
@NDTsocial
Physical exercise:
a polypill against chronic kidney disease
🆓 access: doi.org/10.1093/ndt/gfae062 -
NDT
@NDTsocial
🤩Check out the new December issue of NDT!
academic.oup.com/ndt/issue/40/12 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Natriuretic response to an acute oral K+ load in healthy individuals vs pts with CKD: A RCT
🧐In CKD, K+-induced natriuresis does not occur and oral K+ loading is accompanied by an increased risk of hyperkalemia.
▶️ academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks
🆓 access:
doi.org/10.1093/ndt/gfaf252 -
NDT
@NDTsocial
🎥Watch Paulina Pettinelli present the NDT publication:
Towards carbon footprint measurement for the ERA Congress - five key strategies for greener events
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=0f38995… -
NDT
@NDTsocial
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD
🆓 access: doi.org/10.1093/ndt/gfaf151 -
NDT
@NDTsocial
Repeat ABO-B-incompatible living-donor kidney transplantation
🆓 access:
doi.org/10.1093/ndt/gfaf246 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘Management of Anti GBM Disease
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
The effect of GLP-1 receptor agonists on renal outcomes: a systematic review and meta-analysis
doi.org/10.1093/ndt/gfaf193 -
NDT
@NDTsocial
Practice patterns and outcomes in cancer patients developing immune checkpoint inhibitors–related AKI
doi.org/10.1093/ndt/gfaf191 -
NDT
@NDTsocial
🎥Watch Dr Vanessa Marchant present the NDT publication:
Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b897c59… -
NDT
@NDTsocial
Optimal glucocorticoid therapy in lupus nephritis
doi.org/10.1093/ndt/gfae294 -
NDT
@NDTsocial
🎦Watch Dr Judith Savige present the NDT publication:
ADPKD: predicted pathogenic variants and population frequencies
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c1cd639… -
NDT
@NDTsocial
Anti-glomerular basement membrane disease:
treatment standard
doi.org/10.1093/ndt/gfaf190 -
NDT
@NDTsocial
🎥Watch Dr Maarten Taal present the NDT publication:
🧐Trends in Nephrology:
Decades later, the importance of glomerular hyperfiltration in daily kidney care
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=12d2d8d… -
NDT
@NDTsocial
Immune checkpoint inhibitor–associated nephritis: treatment standard
🆓 access:
doi.org/10.1093/ndt/gfae184 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
💊Powerful visuals on how platinum agents💉, MTX-PemTX & gemcitabine injure the kidneys —
From ROS ⚡ to tubular toxicity 🧫 to full-blown TMA 🩸
A must-see for anyone in #onconephrology 🦀
🔗 doi.org/10.1093/ndt/gfaf251 🆕
#nephtwitter #aki #ckd #tma #chemotherapy #medx -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Trends in nephrology: Cardiovascular Kidney-Metabolic syndrome
🧐For nephrologists, this paradigm offers an opportunity to be involved in interdisciplinary care models.
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf250/8325092 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia
More info: academic.oup.com/ndt/article/40/11/2131/8157900
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents
🧐Understanding these onconephrotoxic agents is essential for optimizing anticancer tx + minimizing nephrotoxicity.
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf251/8325098 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🤩Approach to Renal Amyloidosis
academic.oup.com/ndt/article-abstract/40/10/1826/8043263?…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
🎥Watch Dr Luigi Cirillo present the NDT publication:
Global epidemiology of kidney cancer
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=5ca6e15… -
NDT
@NDTsocial
International consensus on post-transplantation diabetes mellitus
doi.org/10.1093/ndt/gfad258 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🧒IgA Nephropathy Management Pediatric Nephrology Guideline
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
NEW Editorial:
Eliminating sodium with potassium
📖doi.org/10.1093/ndt/gfaf245 -
NDT
@NDTsocial
Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions
doi.org/10.1093/ndt/gfaf249 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Where is the eye of the storm of eGFR formulas?
🧐The EKFC eGFR equation represents an evolution rather than a revolution, offering better performance and flexibility for broader clinical implementation in Europe
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf248/8322407 -
NDT
@NDTsocial
NEW Editorial:
International Pediatric Nephrology Association IgA Nephropathy Guidelines - A commentary
🆓doi.org/10.1093/ndt/gfaf247
📸Algorithm for the initial assessment and management of the patient with IgAN -
NDT
@NDTsocial
Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients
doi.org/10.1093/ndt/gfaf078
#openaccess -
NDT
@NDTsocial
Cholinergic system in patients with chronic kidney disease: cognitive and renal implications
doi.org/10.1093/ndt/gfaf029
#openaccess -
NDT
@NDTsocial
🎥Watch Dr Daniel Tak Mao Chan present the NDT publication:
Chronic Kidney Disease G3-5 in Lupus Nephritis- Prevalence, Progression, and Risk Factors
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=972413b… -
NDT
@NDTsocial
🆕 in NDT:
Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox
🆓 doi.org/10.1093/ndt/gfaf237 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
NsMRA Esaxerenone reduces glomerular hyperfiltration and albuminuria
🧐Esaxerenone restores tubulo-glomerular feedback function via adenosine signaling, attenuating glomerular hyperfiltration and reducing albuminuria
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf232/8316122 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
New Kidneys, Old Risks: Cardiovascular Challenges After Transplantation
🧐Emerging therapies like SGLT2i, GLP-1Ra and nsMRA hold potential but require further validation in this population
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf239/8316146 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Efficacy and safety of finerenone with SGLT2i in IgAN
🧐 Fin-SGLT2i therapy showed superior proteinuria reduction versus monotherapy in IgAN, with preserved kidney function and good safety.
▶️ academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
New kidneys, old risks: cardiovascular challenges after transplantation
doi.org/10.1093/ndt/gfaf239 -
NDT
@NDTsocial
The nonsteroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria in patients with CKD and diabetes
doi.org/10.1093/ndt/gfaf232 -
NDT
@NDTsocial
🎦Watch Dr Maria Vanessa Perez-Gomez present the NDT publication:
Transition of patients with hereditary nephropathies from pediatric to adult care
⬇️⬇️⬇️
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=3106513… -
NDT
@NDTsocial
Life support in hemodialysis emergencies — treatment standard
🆓doi.org/10.1093/ndt/gfaf136 -
NDT
@NDTsocial
🎥Watch this Markus@Home webinar on the NDT publication:
Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group
youtu.be/qjnYDsYbx0Q -
NDT
@NDTsocial
Kidney replacement therapy trajectories of patients with kidney failure: an ERA Registry study
doi.org/10.1093/ndt/gfaf236
@ERAkidney @EraRegistry -
NDT
@NDTsocial
Pulsed ultrasound activation of neural reflexes:
a therapeutic strategy against AKI and inflammation
doi.org/10.1093/ndt/gfaf234 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online at @NDTsocial
Low-Protein Diet Adherence and CKD Progression during long-term follow-up
🧐Low protein diet to attenuate CKD progression still a topic in 2025 (mind the general ongoing high-protein diet trend)
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Kidney replacement therapy for men and women according to the ERA Registry and the USRDS
🔓doi.org/10.1093/ndt/gfaf233
@ERAkidney @EraRegistry -
NDT reposted
markusathome
@MarkusAtHome
Stream it now! Our webinar in cooperation with NDT:
IgA-NP: Treatment Standard & Future Perspective - Prof. Jonathan Barratt, Prof. Jai Radhakrishnan
@IgAN_JBarratt @jradnephro @NDTsocial
@AKronbichler @gunnar_heine @hjanders_hans
youtu.be/l0g9_lkW5_w -
NDT
@NDTsocial
Rationale, design, and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease
🔓doi.org/10.1093/ndt/gfaf230 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🫀Cardiovascular Disease Risk Factors in #ckd
🔹Traditional: HTN, DM, dyslipidemia, obesity, smoking
🔹Non-traditional: anaemia, inflammation, proteinuria, vitamin D deficiency, uraemia
🔹+Extra for dialysis & transplant pts
🔗doi.org/10.1093/ndt/gfae251 🆕
#nephtwitter #ckd #cvd -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Obesity as a modifiable risk factor in pts with CKD
🧐The presence of CKD defines "clinical" versus "preclinical obesity"
▶️ academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Chinese patients
doi.org/10.1093/ndt/gfaf229 -
NDT
@NDTsocial
🧐Trends in nephrology:
decades later, the importance of glomerular hyperfiltration in daily kidney care
🆓doi.org/10.1093/ndt/gfaf228 -
NDT
@NDTsocial
🎥Watch Dr Takamasa Iwakura present the NDT publication:
Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=a118f81… -
NDT
@NDTsocial
From Data to Drug:
The Translational Impact of RaDaR, the UK National Registry of Rare Kidney Diseases
doi.org/10.1093/ndt/gfaf227 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🤩ABCDE Approach to protect kidneys
A-Albuminuria
B-Blood Pressure
C-Cholesterol
D-Diabetes
E-eGFR
@NDTsocial @hjanders_hans
academic.oup.com/ndt/article/40/9/1786/8087355 -
NDT
@NDTsocial
🎥Watch Dr Joerg Latus present the NDT publication:
Clinical course up to 20 years after hantavirus infection
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=a2fe7cb… -
NDT
@NDTsocial
Neutrophil infiltration of kidney grafts:
incidence, associated factors and graft survival
📖doi.org/10.1093/ndt/gfaf219 -
NDT
@NDTsocial
C3G and Ig-MPGN — treatment standard
doi.org/10.1093/ndt/gfad182 -
NDT
@NDTsocial
Tailored management strategies for IgA nephropathy based on clinical presentations
doi.org/10.1093/ndt/gfae289 -
NDT
@NDTsocial
Antibody-mediated rejection in ABO-incompatible kidney transplantation
doi.org/10.1093/ndt/gfaf224 -
NDT
@NDTsocial
Membranous nephropathy treatment standard
🆓doi.org/10.1093/ndt/gfad225 -
NDT
@NDTsocial
The multiple autoantibodies in anti-GBM disease
doi.org/10.1093/ndt/gfaf211 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Nephrotoxicity of Non-Platinum Agents and Miscellaneous Nephrotoxic Drugs
🧐Knowing these kidney toxicity profiles is critical to maximize the oncologic benefit while preserving kidney function.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Jasmine Sethi
@JasmineNephro
💊Drugs to prevent CKD progression
doi.org/10.1093/ndt/gfae216
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
😬🫘Nephrotoxicity of chemotherapy agents
academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Proenkephalin predicts kidney function and major adverse kidney events in CKD
doi.org/10.1093/ndt/gfaf214 -
NDT
@NDTsocial
🎦Watch Dr Sarah Schmitz present the NDT publication:
GLP-1 Receptor Agonists for Kidney Transplant Recipients
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=60b457c… -
NDT
@NDTsocial
Upcoming drug targets for kidney protective effects in chronic kidney disease
doi.org/10.1093/ndt/gfae216
➡️This Review describes the new and promising treatments for CKD
➡️These therapies hold the potential to slow kidney disease and improve the wellbeing of patients -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🔥#complement in renal allograft injury— immune path of graft loss:
🧬#iri→ Lectin (MBL/MASPs), DAMP–TLR → cytokines, NK
⚔️#tcmr→ C3a/C5a amplify T/B cells, Th1/Th17↑, Treg↓
💣#amr→ DSAs→ classical path→ C4d, MAC, VWF→ injury
🔗 doi.org/10.1093/ndt/gfaf206
#tx #nephx #medx -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now ooen access in @NDTsocial
Plasmacytoid DCs modulate the production of mucosal IgA in IgAN
🧐 pDC may be a novel therapeutic target for IgAN
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf216/8287756 -
NDT
@NDTsocial
🧐NDT Insights on Regulatory T Cells:
🥳Celebrating the Nobel Prize in Physiology or Medicine 2025
♥️To celebrate the 2025 Nobel Prize winners, NDT has selected papers on regulatory T cells, which prevent immune cells from attacking our own body
👇👇👇
academic.oup.com/ndt/pages/t-cells-nobel-prize?login=false -
NDT
@NDTsocial
RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1 (PH1)
doi.org/10.1093/ndt/gfaf202 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Impact of preconception kidney function on pregnancy outcomes
🧐Women with eGFR <90 ml/min were at an increased risk of some maternofetal outcomes, the absolute risk remained small
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Here are all our 18 @NDTsocial Treatment Standards so far in a single article collection. More to come...
academic.oup.com/ndt/search-results?f_TocHeadingTitleList… -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘Management of Acute Post streptococcal Glomerulonephritis
doi.org/10.1093/ndt/gfaf130
@NDTsocial @hjanders_hans -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Treatment of relapsing minimal change podocytopathy
More info: academic.oup.com/ndt/article-abstract/40/10/1941/8119395
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
Impact of preconception kidney function on pregnancy outcomes
📖doi.org/10.1093/ndt/gfaf213 -
NDT
@NDTsocial
🎦Watch Dr Laurent Mesnard present the NDT publication:
CKDx is a good start - but can we go further?
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=a64ea38… -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🔥#mras targets fibrosis, inflammation, albuminuria & endothelial dysfunction across heart, kidney & vessels besides BP control
💊Protective in non-diabetic CKD—reducing organ damage & arrhythmia risk.
🔗 doi.org/10.1093/ndt/gfae241
#ckd #nephrology #crs -
NDT
@NDTsocial
Hyperkalemia risk of finerenone versus spironolactone in CKD patients with type 2 diabetes
doi.org/10.1093/ndt/gfaf098
➡️In this study of patients with T2DM and CKD, finerenone is associated with less hyperkalemia risk than spironolactone -
NDT
@NDTsocial
Clinical course up to 20 years after hantavirus infection
doi.org/10.1093/ndt/gfaf212 -
NDT reposted
Daniel Díaz - García
@DanielDiazNF
Urinary sediment predicts active proliferative glomerular diseases
In predicting:
▫️AUC RBC: 0.86 and WBC: 0.83
▫️AUC RBC + WBC: 0.88
▫️AUC RBC+WBC+RTEC+RBC casts: 0.90
▫️AUC gender+age+serum creatinine + urine proteins: 0.8
▫️AUC all these variables: 0.96 -
NDT reposted
Edgar V. Lerma 🇵🇭
@edgarvlermamd
Pathogenesis of #igan and emerging targets 🎯 ca. 2025 from @NDTsocial
#rkdsummit #nephpearls
👉🏼 pubmed.ncbi.nlm.nih.gov/40796290/ -
NDT
@NDTsocial
International consensus on post-transplantation diabetes mellitus
doi.org/10.1093/ndt/gfad258 -
NDT
@NDTsocial
Recommended calcium intake in adults and children with chronic kidney disease - a European consensus statement
doi.org/10.1093/ndt/gfad185 -
NDT
@NDTsocial
Comparison of estimated glomerular filtration rate equations on prediction of mortality, kidney failure and acute kidney injury
doi.org/10.1093/ndt/gfaf054 -
NDT
@NDTsocial
Sex-specific cardiac dysfunction in mice with chronic kidney disease
doi.org/10.1093/ndt/gfaf056 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
How should we target and reduce the production of pathogenic IgA in IgAN?
🧐Drugs directed at mucosal B cell priming, inhibitors of APRIL and BAFF, and drugs that target IgA-producing plasma cells
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf185/8262262 -
NDT
@NDTsocial
Active glomerular inflammation versus chronicity and fibrosis:
the role of targeted therapies in IgA nephropathy
🔓doi.org/10.1093/ndt/gfaf059 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Efficacy and Safety of Telitacicept in Adult IgAV Nephropathy
🧐Additional telitacicept significantly increased the complete remission rate of IgAVN, without serious adverse events.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Urinary sediment predicts active proliferative glomerular diseases
🧐U-sed alone was superior to gender/age/SCr/UACR (AUC=0.84). When added to these variables, U-sed reached the AUC of 0.96
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Complement activation in kidney transplantation
doi.org/10.1093/ndt/gfaf206 -
NDT
@NDTsocial
🎥Watch Dr Maria Vargas present the NDT publication:
Monoclonal gammopathy and its associations with kidney failure in patients with ANCA-associated vasculitis
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=62efab9… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Eculizumab for rapidly progressive glomerulonephritis
🧐Eculizumab, by rapidly suppressing complement attack and inflammation during the active phase of RPGN, may serve as a promising add-on therapeutic agent.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
Review on Renal amyloidosis
More info: academic.oup.com/ndt/article-abstract/40/10/1826/8043263
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Anti-nephrin antibodies in patients with IgAN and nephrotic syndrome
🧐The majority of MCD-IgAN patients were positive for circulating anti-nephrin antibodies!
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
🧐How to individualize renoprotective therapy in obese patients with chronic kidney disease:
a commentary by the Diabesity Working Group of the ERA
🔓doi.org/10.1093/ndt/gfaf069
@ERAkidney -
NDT
@NDTsocial
SGLT2 inhibitors in CKD:
🤔are they really effective in all patients?
🆓 doi.org/10.1093/ndt/gfaf051 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🔥IgA Nephropathy has 2 faces:
🩸Inflammation→ proteinuria, hematuria, crescents, rapid eGFR fall
🧱Fibrosis → slow decline, TIF/TA, minimal hematuria
🎯Tx: steroids, budesonide, iptacopan➝ SGLT2i, RAASi, DEARA
🔗doi.org/10.1093/ndt/gfaf059 🆕@NDTsocial
#igan #ckd #nephrology -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
GLP-1 Receptor Agonists for Kidney Transplant Recipients
🧐A multidisciplinary and patient-centered approach is essential to guide their safe and effective use in KTRs
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Acute post-streptococcal glomerulonephritis in children— treatment standard
doi.org/10.1093/ndt/gfaf130 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Recombinant alpha-1 microglobulin to improve outcomes in survivors of AKI
🧐RMC-035 may improve kidney outcomes in settings characterized by oxidative and ischemia-reperfusion injury.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
🤩Check out the new October issue of NDT!
academic.oup.com/ndt/issue/40/10 -
NDT
@NDTsocial
Is psoriasis associated with increased risk of graft failure in kidney #transplant recipients? 🤔
@NDTsocial @hjanders_hans
@ERAkidney
🧵by @smirioglu
doi.org/10.1093/ndt/gfaf047
NDT
@NDTsocial
Patients with #psoriasis have been found to have a significantly increased risk of developing #ckd and ESKD, but the relationship between psoriasis and graft failure after #transplantation has not been established.
Post not available here, view on X
NDT
@NDTsocial
Please do not forget that this is a retrospective cohort study and the findings do not imply causation! 📝
NDT
@NDTsocial
Check @NDTsocial for more content from the Journal!
-
NDT reposted
Gunnar Henrik Heine
@gunnar_heine
No antiproteinuric effect of SGLT2-inhibitors in non-diabetic glomerulopathies & normal BMI?
A @NDTsocial cohort by @fcaravacafontan @PRomagnani @fervenzafernan1
BUT: In @willkidney's EMPA-KIDNEY RCT, CKD pat with normal BMI DID benefit from EMPA
academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf197/8263928 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
QT-Prolonging Medications: Prevalence of Use and Associated Risks in CKD
🧐The pathophysiological relevance, prevalence, and CV consequences of QT-prolonging drug use in the CKD setting
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf196/8263915 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘👍Combination therapy in CKD
doi.org/10.1093/ndt/gfae212
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
What are the right endpoints to assess the effectiveness of new treatments for IgAN?
🆓doi.org/10.1093/ndt/gfaf184 -
NDT
@NDTsocial
The effect of GLP-1 receptor agonists on renal outcomes: a systematic review and meta-analysis
doi.org/10.1093/ndt/gfaf193 -
NDT
@NDTsocial
Monoclonal gammopathy associates with kidney failure in ANCA-associated vasculitis
doi.org/10.1093/ndt/gfaf195 -
NDT
@NDTsocial
Immune checkpoint inhibitor–associated nephritis —treatment standard
🆓doi.org/10.1093/ndt/gfae184 -
NDT
@NDTsocial
Placement of tunnelled haemodialysis catheters —interventional standard
🆓doi.org/10.1093/ndt/gfae181 -
NDT
@NDTsocial
Tailored management strategies for IgA nephropathy based on clinical presentations
doi.org/10.1093/ndt/gfae289
👉This review proposes therapeutic algorithms to guide treatment decisions in different clinical scenarios while highlighting gaps in current research -
NDT
@NDTsocial
Optimal glucocorticoid therapy in lupus nephritis
🔓doi.org/10.1093/ndt/gfae294
➡️This review provides an in-depth analysis of glucocorticoid therapy for lupus nephritis, a severe manifestation of systemic lupus erythematosus that affects up to 51.7% of patients -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Anti-GBM disease - Treatment Standard
🧐 Anti-GBM and ANCA positive pts have a higher relapse risk and require maintenance immunosuppressive treatment
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf190/8257581 -
NDT
@NDTsocial
🎦Watch Dr Phillip Blanchette present the NDT publication:
Practice Patterns and Outcomes in Cancer Patients Developing Immune Checkpoint Inhibitor - related Acute Kidney Injury
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=9030d1b… -
NDT
@NDTsocial
Personalized disease recurrence modeling using iPSC-derived podocytes in patients with idiopathic nephrotic syndrome
doi.org/10.1093/ndt/gfaf045
➡️In vitro assays using iPSC-derived donor podocytes may allow individualized assessment of rFSGS -
NDT
@NDTsocial
Characteristics and cardio-renal outcomes in CKD patients receiving guideline-directed therapy:
insights from DISCOVER CKD
🔓doi.org/10.1093/ndt/gfaf175 -
NDT
@NDTsocial
🎥Watch Dr Xianghua Huang present the NDT publication:
Kidney disease after hematopoietic stem cell transplant - Treatment Standard
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=0333c59… -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
⏱️ Timing matters in anti-nephrin antibody detection in Autoimmune #ns 🫘
Phase-dependent variability shapes what we see:
🔬ELISA vs biopsy microscopy
💧Proteinuria as a moving target
🧬Clinical phases from onset→ relapse
👉 doi.org/10.1093/ndt/gfaf156
#nephrology #mcd -
NDT
@NDTsocial
Early compensatory increase in single-kidney estimated GFR after unilateral nephrectomy is associated with a lower long-term risk of estimated GFR decline
🔓doi.org/10.1093/ndt/gfaf026 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Comparing CKD populations with T1D and T2D based on FINE-ONE and FIDELITY populations
🧐Similarities between populations may inform the translation of clinical evidence on finerenone from CKD and T2D to CKD and T1D.
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf183/8251659 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Check out the new entries of the Kidney Art gallery
@ERAkidney @NDTsocial
Don`t hesitate to submit your creative kidney art, too? You may end on the cover page of NDT...
www.era-online.org/ndt-kidney-art-gallery/ -
NDT
@NDTsocial
🎥Watch Dr Judith Savige present the NDT publication:
ADPKD: predicted pathogenic variants and population frequencies
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c1cd639… -
NDT
@NDTsocial
🧐Trends in Nephrology:
from “translational research” in animals to research in humans
🆓doi.org/10.1093/ndt/gfaf157 -
NDT
@NDTsocial
Care pathways for patients with cognitive impairment and chronic kidney disease
🔓doi.org/10.1093/ndt/gfae264 -
NDT
@NDTsocial
Additive renoprotective effects of oral calcitriol on patients with IgA nephropathy receiving RAS blockade
doi.org/10.1093/ndt/gfaf187 -
NDT
@NDTsocial
Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD
doi.org/10.1093/ndt/gfaf064 -
NDT
@NDTsocial
🎦Watch Dr Valentina Raglianti present the NDT publication:
Anti-nephrin, anti-podocin and anti-kirrel1 autoantibodies: biological challenges and clinical implications
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=8c7ead8… -
NDT
@NDTsocial
Cognitive impairment in kidney transplanted patients
doi.org/10.1093/ndt/gfae250 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘Renal Amyloidosis Approach
@NDTsocial @hjanders_hans
academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Chemotherapy-related cognitive impairment and kidney dysfunction
doi.org/10.1093/ndt/gfae249 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Protein profiles and associated biological pathways among different etiologies of CKD: new insights from DAPA-CKD
🧐Distinct proteomic differences unravel the heterogeneous pathophysiology of human CKD.
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf180/8249290 -
NDT
@NDTsocial
🧐Check out this NDT Supplement:
CONNECT: What Has Been Done and What Needs to Be Done
academic.oup.com/ndt/issue/40/Supplement_2 -
NDT
@NDTsocial
🎥Watch Dr Alexandre Andrade present the NDT publication:
Cognitive impairment in chronic kidney disease: Role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=52c406e… -
NDT
@NDTsocial
The role of the intestinal microbiome in cognitive decline in patients with kidney disease
doi.org/10.1093/ndt/gfae253 -
NDT
@NDTsocial
Personalized disease recurrence modeling using iPSC-derived podocytes in patients with idiopathic nephrotic syndrome
doi.org/10.1093/ndt/gfaf045
➡️In vitro assays using iPSC-derived donor podocytes may allow individualized assessment of rFSGS -
NDT
@NDTsocial
Real world data on dual BLyS/APRIL inhibition with telitacicept for lupus nephritis
doi.org/10.1093/ndt/gfaf049 -
NDT
@NDTsocial
The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD
doi.org/10.1093/ndt/gfaf048 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫶CONFIDENCE trial-Simultaneous initiation of Empa And Finerenone is beneficial in Type 2 Diabetes and CKD
doi.org/10.1093/ndt/gfaf160
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘👍Four Hit model of IgA Nephropathy
doi.org/10.1093/ndt/gfaf144
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
👵👴CKD in Elderly -Conservative care or RRT ???
doi.org/10.1093/ndt/gfaf115
@NDTsocial @hjanders_hans -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🧬 IgA Nephropathy: 4 pathogenic hits, 1 evolving story!
🎯 From B-cell targeting to complement inhibition & novel agents against proteinuria—precision therapies are reshaping outcomes 💊🌟
🔗 doi.org/10.1093/ndt/gfaf144
@NDTsocial
#igan #nephrology #glomerulardisease #ckd #medx -
NDT
@NDTsocial
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial
🆓doi.org/10.1093/ndt/gfaf160 -
NDT
@NDTsocial
📽️Watch Dr Susana Arjona present the NDT publication:
The unmet need of electrolyte supplements
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=a6ac0a1… -
NDT
@NDTsocial
Trends in home dialysis over the last decade in Europe: an ERA Registry study
doi.org/10.1093/ndt/gfaf171 -
NDT
@NDTsocial
IGFBP-5/TGF-β1-mediated crosstalk between endothelial and tubular epithelial cells promotes interstitial fibrosis
doi.org/10.1093/ndt/gfaf179 -
NDT reposted
Rajiv Agarwal MD, MS
@AgarwalRajivMD
Fantastic new publication from @mvaduganathan in academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf…. The findings reinforce a crucial point: high-risk patients stand to gain a lot from the combination of finerenone and SGLT2i. The longer we wait, the more patients may be at risk. Thank you @NDTsocial
Hany Ragy
@Hragy
Whoaaaaa! Full hall Budapest hall 10 at 8:15 am!
Finerenone combo Empa in Confidence trial better than each alone in Kidney protection
@mmamas1973 talking next! Come stand at the back! #esccongress -
NDT
@NDTsocial
Treatment standard: CKD in the geriatric patient
doi.org/10.1093/ndt/gfaf115 -
NDT
@NDTsocial
🥳The September issue of NDT is online!
👇👇👇
academic.oup.com/ndt/issue/40/9 -
NDT
@NDTsocial
Combination therapy:
an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease
🔓doi.org/10.1093/ndt/gfae212 -
NDT
@NDTsocial
67 national-level factors potentially related to the incidence of kidney replacement therapy across Europe
🔓doi.org/10.1093/ndt/gfaf163
👉These findings may be a first step to optimize healthcare regarding KRT initiation & reduce KRT incidence disparities -
NDT reposted
Yuki Nakao
@yuki_nakao1
📢 New Publication!
Our paper on SGLT2 inhibitors and acute kidney injury has just been published in Nephrology Dialysis Transplantation @NDTsocial . Grateful to my co-authors and mentors for their support🙏
#sglt2inhibitors #aki
academic.oup.com/ndt/advance-article-abstract/doi/10.1093… -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘🙌New promising nephroprotective drugs for CKD
doi.org/10.1093/ndt/gfae216
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
📢Call for NDT Cover Images
🥳NDT is excited to announce a call for the cover images for our future NDT issues
🧐If you have an eye-catching image focused on kidney disease, email it to ndt@era-online.org
❤️All images will also be featured in the NDT Kidney Art Gallery -
NDT
@NDTsocial
Nephrotoxicity and kidney outcomes in pediatric oncology patients
🔓doi.org/10.1093/ndt/gfaf169 -
NDT
@NDTsocial
Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application
🔓doi.org/10.1093/ndt/gfae214 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
How to interpret the number needed to treat for clinicians
🧐 What you expect when your MD recommends you something to solve you a problem (a surgery, a pill)?
A NNT of 1:1 or 1:20? How is the NNH? (number needed to harm)?
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf168/8239294 -
NDT
@NDTsocial
Association of urinary LIF levels with disease prognosis and treatment response to methylprednisolone in IgA nephropathy
doi.org/10.1093/ndt/gfaf164 -
NDT
@NDTsocial
Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUS
doi.org/10.1093/ndt/gfaf166 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
How to interpret the number needed to treat for clinicians
🧐Evidence-based medicine: NNT 1:10-40 seems ok
Personalized medicine: NNT 1:1 only
academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf168/8239294 -
NDT
@NDTsocial
Upcoming drug targets for kidney protective effects in chronic kidney disease
➡️This review describes the new and promising treatments for CKD. These therapies hold the potential to slow kidney disease and improve the wellbeing of patients.
🔓doi.org/10.1093/ndt/gfae216 -
NDT
@NDTsocial
🎥Watch Dr Andreas Kronbichler present the NDT publication:
Antibody-mediated podocytopathies: a disease entity that implies immunotherapy
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=0f173e6… -
NDT
@NDTsocial
The unmet need of electrolyte supplements
doi.org/10.1093/ndt/gfaf161 -
NDT reposted
Jasmine Sethi
@JasmineNephro
⏬When to suspect Renal Artery Stenosis 🤔
academic.oup.com/ndt/article/38/12/2835/7172140
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
How to interpret the number needed to treat for clinicians
doi.org/10.1093/ndt/gfaf168 -
NDT
@NDTsocial
🎥Watch Dr Vincenzo Bellizzi present the NDT publication:
Cost-effectiveness of protein-restricted diets in advanced CKD
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=4f141fe… -
NDT reposted
Jasmine Sethi
@JasmineNephro
👍Complement pathways and targets in IgA Nephropathy
doi.org/10.1093/ndt/gfaf135
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
🆕🆕 what’s new in Nephrotic Syndrome???
✅Anti Nephrin/anti-podocin & anti-Kirrel1 antibodies for diagnosis and precision management
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Red blood cell casts on kidney biopsy and progression of IgA nephropathy
doi.org/10.1093/ndt/gfaf023 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🫘🧬 CKD & AKI 🔄 fuel a vicious cycle →
loss of 🧩Klotho, 🧪uremic toxins, 🔥inflammation & broken 🔗 organ crosstalk → 🚀 accelerated aging ❤️🧠💪 (CVD, frailty, cognition).
A positive feedback loop we must break! ⏳💥
🔗 doi.org/10.1093/ndt/gfaf068
#nephrology #aging #ckd -
NDT reposted
Jasmine Sethi
@JasmineNephro
👍HDF 🆚 High flux hemodialysis
academic.oup.com/ndt/article/40/8/1590/8003757
💀All cause mortality lower with HDF than high flux HD
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies:
Biological challenges and clinical implications
🔓doi.org/10.1093/ndt/gfaf156 -
NDT
@NDTsocial
Changing from the CKD-EPI to the EKFC creatinine equation to estimate glomerular filtration rate in adults in a Northern European health system
doi.org/10.1093/ndt/gfaf148 -
NDT
@NDTsocial
Cost-effectiveness of protein restricted diets in moderate to advanced CKD
doi.org/10.1093/ndt/gfaf154 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial @ERAkidney
More versus less intensive BP reduction and kidney function outcomes—Waiting for Godot?
🧐 Why is eGFR loss resistant to intense BP intervention? Because HTN is the consequence not the cause of eGFR loss!
▶️academic.oup.com/ndt/article/40/8/1452/8043264 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🔄💉#hd vs #hdf: not just acronyms, but different clearance mechanisms!
🧪Diffusion rules #haemodialysis,
Convection drives #haemodiafiltration
📊ERA–EuDial Consensus:HDF clears more middle molecules & may offer clinical edge
🔗doi.org/10.1093/ndt/gfaf024
#nephrology #dialysis -
NDT reposted
Paola Romagnani
@PRomagnani
Can anti-nephrin, anti-podocin & anti-Kirrel1 antibodies guide diagnosis & therapy in podocytopathies?
Our new review in NDT dives into the biological hurdles & clinical implications.
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf… -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🩺 Protect your kidneys🫘 with ABCDE 🧩
A 🧪 Albuminuria
B 💓 Blood pressure
C 🩸 Cholesterol
D 🍬 Diabetes
E 🔬 eGFR
Early checks = stronger 💙 & healthier kidneys!
🔗 doi.org/10.1093/ndt/gfaf057
@NDTsocial
#kidney #ckd #nephrology #medtwitter -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Cost-effectiveness of protein restricted diets in advanced CKD
🧐In pts adherent to diet prescription, low-protein diets delay the start of dialysis, improve survival, and save money
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
🎥Watch Dr Dario Rocatello present the NDT publication:
Fibrillary glomerulonephritis: lessons from anti-CDro therapy and repeat biopsy
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=baae4c2… -
NDT
@NDTsocial
KDIGO 2025 ADPKD Guideline:
A commentary on diagnosis and management of hepatopancreatic manifestations by the ERA Working Group Genes & Kidney
@ERAkidney
🆓doi.org/10.1093/ndt/gfaf159 -
NDT
@NDTsocial
🧐Trends in nephrology:
➡️kidney metabolism as a therapeutic target
🆓doi.org/10.1093/ndt/gfaf155 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial @ERAkidney
What do RCTs teach us about the pathophysiology of human IgAN?
🧐B cells/PC produce the IgAN antigen GdIgA1 as well as the respective autoantibodies, hence targeting B cells/PC will be most clever.
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf144/8232667 -
NDT
@NDTsocial
🎥Watch Dr Aurora Caldinelli present the NDT publication:
Risk-based referral model to nephrologist-specialist care in Stockholm
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=e400c8f… -
NDT
@NDTsocial
🧐Read this interesting debate in NDT!
*CKDx: a necessary step—but can we go further?
🆓doi.org/10.1093/ndt/gfaf138
*CKDx: simplicity matters, implementation is key
🆓doi.org/10.1093/ndt/gfaf137 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease
🧐Triple-positive pts (anti-type IV collagen, -laminin 521, and -perlecan) = highest prevalence of lung hemorrhage and ESKD
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial @ERAkidney
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD
🧐"Inferior doctors provide KRT
Mediocre doctors treat CKD
Superior doctors prevent kidney disease"
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf151/8228479 -
NDT
@NDTsocial
🎥Watch Dr Laurent Mesnard present the NDT publication:
CKDx is a good start - But can we go further?
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=a64ea38… -
NDT
@NDTsocial
Trends in nephrology: from reducing proteinuria with steroids to curing glomerulonephritis
🆓doi.org/10.1093/ndt/gfaf152 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘✅Hyperkalemia Management
😎Potassium binders
✅Sodium Polystyrene sulphate
✅Patiromer
✅Sodium Zirconium cyclosilicate
@NDTsocial @hjanders_hans
academic.oup.com/ndt/advance-article-abstract/doi/10.1093… -
NDT reposted
Jasmine Sethi
@JasmineNephro
🧬Complement pathways and drugs targetting them in IgA Nephropathy
doi.org/10.1093/ndt/gfaf135
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
New formulas for calculating dialysis dose in incremental haemodialysis
doi.org/10.1093/ndt/gfaf147 -
NDT
@NDTsocial
📽️Watch Dr Laurent Mesnard present the NDT publication:
CKDx is a good start - But can we go further?
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=a64ea38… -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
More RBC casts in a case of IgAN? might mean treatable and reversible
More info: academic.oup.com/ndt/article/40/8/1570/8002859
Image courtesy: @RenalFellowNtwk/X
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
CONFIDENCE trial: You know the population; now we await the results...
More info: academic.oup.com/ndt/article/40/8/1559/7997692
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT
@NDTsocial
🎥Watch Dr Remi Brasme present the NDT publication:
Recurrence of CKD-associated pruritus after discontinuation of Difelikefalin
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=84c15ec… -
NDT
@NDTsocial
🧐How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?
📖doi.org/10.1093/ndt/gfaf135 -
NDT
@NDTsocial
The environmental and genetic architectures of ageing and CKD
🆓doi.org/10.1093/ndt/gfaf146 -
NDT
@NDTsocial
🎥Watch Xianghua Huang present the NDT publication:
Kidney disease after hematopoietic stem cell transplant - Treatment Standard
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=0333c59… -
NDT
@NDTsocial
PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy
doi.org/10.1093/ndt/gfaf012 -
NDT
@NDTsocial
Nephrology meets AI—environmental perspective
doi.org/10.1093/ndt/gfaf027 -
NDT
@NDTsocial
📽️Watch Dr Mabel Aoun present the NDT publication:
Life Support in Hemodialysis Emergencies-Treatment Standard
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=755913a… -
NDT
@NDTsocial
Physical activity and cardiorenal health—from associations to interventional studies
doi.org/10.1093/ndt/gfae251 -
NDT
@NDTsocial
Association between exposure to air pollution and kidney function decline
📖doi.org/10.1093/ndt/gfaf143
❗️Air pollution exposure accelerates kidney function decline, necessitating public health action❗️ -
NDT reposted
Jasmine Sethi
@JasmineNephro
💊Steroid dosing in Lupus Nephritis
@NDTsocial @hjanders_hans
doi.org/10.1093/ndt/gfae294 -
NDT reposted
María Peris
@mapefer3
⚠️ Hemodialysis: more than just toxin removal
❌ Also depletes protective metabolites (L-carnitine, quinic acid...)
🧠💥 Disrupts mitochondrial function and energy balance
📖 Read our NDT study 👉 doi.org/10.1093/ndt/gfaf145
@NDTsocial @IISLaFe @Nefro_LaFe #nephrology #metabolomics -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘Pillars of care in CKD
@NDTsocial @hjanders_hans
academic.oup.com/ndt/article/40/Supplement_1/i59/8002192 -
NDT
@NDTsocial
🥳The August issue is online!
academic.oup.com/ndt/issue/40/8
🧐Editor's choice:
Antibody-mediated rejection—treatment standard
doi.org/10.1093/ndt/gfaf097 -
NDT reposted
AIN/Sandipan Shringi
@Nephrosage
In-depth review on optimizing steroid use in Lupus nephritis.
More info: academic.oup.com/ndt/article/40/7/1284/7929884
@NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🚨What to do when a dialysis patient collapses?🤕🫘
💥From CAB to XT-ABCDE, here’s your visual 🔑 to managing life-threatening emergencies in #hemodialysis 💪
👉🏻Every HD unit needs this!
🔗 doi.org/10.1093/ndt/gfaf136 🆕 🆓
#medtwitter #foamed #meded #hd #resus #nephrology 🩺 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘👍Kidney Disease post hematopoitic stem cell transplant
academic.oup.com/ndt/advance-article-abstract/doi/10.1093…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
SGLT2 inhibitors and acute kidney injury
doi.org/10.1093/ndt/gfaf132 -
NDT
@NDTsocial
Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial
doi.org/10.1093/ndt/gfae282 -
NDT
@NDTsocial
Estimated potassium intake and the progression of chronic kidney disease
doi.org/10.1093/ndt/gfae277 -
NDT
@NDTsocial
🎥Watch Solene Laville present the NDT publication:
Male and female Drug Prescription Patterns and Adverse Drug Reactions in Chronic Kidney Disease
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=12449af… -
NDT
@NDTsocial
Prevalence of reduced eGFR in European adults using KDIGO and age-adapted eGFR thresholds
🔓doi.org/10.1093/ndt/gfaf112 -
NDT
@NDTsocial
📽️Watch Katherine Clark present the NDT publication:
Nephrocheck AKI Risk Scores (TIMP-2 and IGFBP7) in Pregnancy
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f3dc472… -
NDT
@NDTsocial
Kidney disease after hematopoietic stem cell transplant - treatment standard
doi.org/10.1093/ndt/gfaf139 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🚨Post-HSCT Kidney Disease?
Check this 🔥flowchart mapping AKI, CKD & glomerular pathologies incl. TA-TMA, MN ➕ treatment!
💊Eculizumab, Rituximab, CNIs & more
📖Must-read for every #nephrologist!
@NDTsocial
🔗doi.org/10.1093/ndt/gfaf139 🆓
#medtwitter #nephrology #ktx #hsct -
NDT
@NDTsocial
Life support in hemodialysis emergencies – treatment standard
doi.org/10.1093/ndt/gfaf136 -
NDT
@NDTsocial
🤩NEW in NDT!
Trends in nephrology:
From „diabetic kidney disease” to „CKD with risk factor diabetes”
🆓doi.org/10.1093/ndt/gfaf134 -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
When to use spironolactone, eplerenone or finerenone in the spectrum of cardiorenal diseases
academic.oup.com/ndt/article/39/7/1063/7513181
An amazing article from the high impact articles published @NDTsocial @hjanders_hans -
NDT reposted
Mohamed E. Elrggal
@M_Elraggal
Read this piece from the ERAKI working group at the
@NDTsocial regarding the results of the DEFENDER trial published last August @JAMA_current
academic.oup.com/ndt/article/40/7/1267/7954741 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🧒 Approach to Childhood acute post streptococcal Glomerulonephritis
academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Acute post-streptococcal glomerulonephritis in children - treatment standard
doi.org/10.1093/ndt/gfaf130 -
NDT
@NDTsocial
Is 2-week prophylactic direct antiviral treatment safe and effective in HCV positive-to-negative kidney transplant recipients? 👀
@NDTsocial @hjanders_hans
@ERAkidney
🧵by @smirioglu
doi.org/10.1093/ndt/gfae271Post not available here, view on X
NDT
@NDTsocial
A 14-day course of prophylactic GLE/PIB was found safe and effective for HCV positive-to-negative kidney transplantation. 😎
NDT
@NDTsocial
Check @NDTsocial for more content from the Journal!
-
NDT reposted
Marco Allinovi
@MarcoAllinovi
Patients with membranous nephropathy treated with rituximab exhibit enhanced drug clearance due to urinary loss (rituximab underexposure), particularly in those with reduced eGFR and non-selective proteinuria. @NDTsocial
doi.org/10.1093/ndt/gfaf127 -
NDT
@NDTsocial
🎥Watch Marta Casal Moura present the NDT publication:
Sex-specific clinical presentations and outcomes in ANCA vasculitis presenting with severe kidney disease
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=46f8071… -
NDT
@NDTsocial
Risk-based referral model to nephrologist-specialist care in Stockholm
doi.org/10.1093/ndt/gfaf128 -
NDT
@NDTsocial
Effect of haemodialysis on the brain and heart assessed using multiparametric MRI
doi.org/10.1093/ndt/gfaf117 -
NDT reposted
Jasmine Sethi
@JasmineNephro
❤️🩹🫘Pathophysiology of Cardiorenal syndrome
doi.org/10.1093/ndt/gfaf009
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘👍Managing Secondary TMA
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf…
@NDTsocial @hjanders_hans -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
👶Aguascalientes nephropathy🫘 teaches us: CKD often starts even before birth!
👶Low nephron endowment→ early FSGS
🧓2nd CKD peak(50–70 yrs)→ driven by DM, HTN, toxins
👊🏻Early hits+ lifelong exposures= #ckd
doi.org/10.1093/ndt/gfaf122
#nephtwitter #nephrology #prenatalcare -
NDT
@NDTsocial
Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial
doi.org/10.1093/ndt/gfaf119 -
NDT
@NDTsocial
Cost-effectiveness of a ketoanalogue-supplemented very low-protein diet in CKD
doi.org/10.1093/ndt/gfaf123 -
NDT
@NDTsocial
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
doi.org/10.1093/ndt/gfaf127 -
NDT
@NDTsocial
Sex-specific clinical presentations and outcomes in ANCA vasculitis presenting with severe kidney disease
doi.org/10.1093/ndt/gfaf120 -
NDT reposted
Johann Morelle
@JohannMorelle
#complement Activation in Secondary Thrombotic Microangiopathies (#tma)
✅ Final version available in #openaccess in @NDTsocial
➡️ academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf…
🙏 experts, colleagues and friends; the @ERAkidney Immunonephrology Working Group; and @AKronbichler for your leadership! -
NDT reposted
Jasmine Sethi
@JasmineNephro
💊Steroid dosing in Lupus Nephritis
doi.org/10.1093/ndt/gfae294
@NDTsocial @hjanders_hans -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
CKD is NOT a single disease — it’s a final common pathway of diverse hits!
🧬Ischemic, immunologic, toxic, DM, AKI, obstruction — all funnel into renal injury
⚠️Glomerular vs tubular pathways → FSGS vs IFTA
🔗doi.org/10.1093/ndt/gfaf122 🆕
#nephtwitter #ckd #fsgs #aki #meded -
NDT
@NDTsocial
🎥Watch Remi Brasme present the NDT publication:
Recurrence of CKD-associated pruritus after discontinuation of Difelikefalin
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=84c15ec… -
NDT
@NDTsocial
Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure
doi.org/10.1093/ndt/gfaf083 -
NDT
@NDTsocial
🎥Watch Elke Schaeffner present the NDT publication:
Treatment standard: CKD in the geriatric patient
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=ce16115… -
NDT
@NDTsocial
Kidney function and mortality in childhood nephrotic syndrome
doi.org/10.1093/ndt/gfaf118 -
NDT
@NDTsocial
🎥Watch Hanne Skou Jørgensen present the NDT publication:
Recommended calcium intake in adults and children with chronic kidney disease – a European consensus statement
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=0664ee1… -
NDT
@NDTsocial
Optimal glucocorticoid therapy in lupus nephritis
🆓doi.org/10.1093/ndt/gfae294 -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
💊Steroids in Lupus Nephritis: friend or foe?🤝👊🏻
⚠️From 🦴osteoporosis to 😷 infections — the side effects are real!
✅Here’s how to tackle them smartly👇
🔗 doi.org/10.1093/ndt/gfae294 🆕 @NDTSocial
#nephtwitter #lupus #medtwitter #rheumtwitter #nephrology #meded #ln -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘GLP-1 RA in Metabolic Disease
😬⏬Obesity related complications
doi.org/10.1093/ndt/gfaf110
@NDTsocial @hjanders_hans -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
Cardiorenal Syndrome #crs =One organ bleeds, the other scars
🫀+🫘= 🧬Fibrosis via TGF-β, CTGF, Gal-3, FGF-23
💥Macrophage shifts.
🧫EVs, Collagen storm, Crosslinking 🕸️
📊 Bench to Bedside story in 2 panels!
🔗doi.org/10.1093/ndt/gfaf009 🆕
#nephtwitter #cardiotwitter #fibrosis -
NDT reposted
Gopambuj Singh Rathod
@IamGopambuj
💊DEFENDER trial - a trial that challenges the concept of not using SGLT2i in critically ill patients
📚🔰Read in details in the new edition of @NDTsocial
#nephx #medtwitter #buddingnephros #gsr #sglt2 -
NDT
@NDTsocial
🥳The July issue is now out!
➡️academic.oup.com/ndt/issue -
NDT reposted
Raad Chowdhury, MD, FASN
@rc_oncneph
Our @ndtsocial editorial on "nephrotoxicity" of bortezomib in #myeloma
🙏🏽 to have 🌎 experts in heme and renal contribute.
A great review of positive heme/renal/patient impact of bortezomib
E. Kastritis
@VincentRK
N. Leung
@MayoClinicNeph
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfad… -
NDT
@NDTsocial
Foam sclerotherapy for symptomatic cysts in ADPKD, ADPLD and solitary cysts
doi.org/10.1093/ndt/gfaf111 -
NDT
@NDTsocial
🎥Watch Thei Steenvoorden present the NDT publication:
Alkaline phosphatase treatment of acute kidney injury - an update
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f848862… -
NDT
@NDTsocial
GLP-1-based therapeutics for cardiorenal protection in metabolic diseases
🆓doi.org/10.1093/ndt/gfaf110 -
NDT
@NDTsocial
Rituximab-induced persistent hypogammaglobulinemia in children with nephrotic syndrome: common or rare?
🆓doi.org/10.1093/ndt/gfaf103 -
NDT
@NDTsocial
Novel and traditional B-cell depleting agents for IgG4-related disease: a critical view
🆓doi.org/10.1093/ndt/gfaf108 -
NDT
@NDTsocial
🎥Watch Georg Boehmig present the NDT publication:
Antibody-mediated Rejection- Treatment Standard
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=cfcfa34… -
NDT reposted
Daniel Díaz - García
@DanielDiazNF
Clinical Phenotypes and Renal Outcomes in PLA2R-positive MN:
▫️Predictors of remission reduction:
-Anti-PLA2R: >100 U/ml; HR 0.56, (0.36-0.88), P=0.01
-Proteinuria: >8 g/24 h; HR 0.43 (0.26-0.73) P=0.002
▫️High HDL levels were protective: HR 1.01 (1.00-1.02), P=0.048 -
NDT reposted
ERA - European Renal Association
@ERAkidney
🎉 We're proud to share the latest Impact Factors and CiteScores for our leading nephrology journals Nephrology Dialysis Transplantation (NDT) and Clinical Kidney Journal (CKJ).
🙏 Thanks to the exceptional contributions of our authors, reviewers, readers, and editorial board. -
NDT
@NDTsocial
🎥Watch Emilie Cornec-Le Gall present the NDT publication:
Chronic kidney disease of unexplained cause ( CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA
@ERAkidney
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=206ac93… -
NDT
@NDTsocial
Global, regional, and national burden of renal anemia, 1990 to 2019 and prediction to 2050
doi.org/10.1093/ndt/gfaf102 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘Pillars of care in CKD
academic.oup.com/ndt/article/40/Supplement_1/i59/8002192
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
🩺 Management of IgA Nephropathy
doi.org/10.1093/ndt/gfae289
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Lipid lowering agents in solid organ transplant recipients
🆓doi.org/10.1093/ndt/gfaf104 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘❤️🩹Diuretics in Heart failure
academic.oup.com/ndt/pages/joint-era-and-esc-cardio-kidne…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Lipid lowering agents in solid organ transplant recipients
doi.org/10.1093/ndt/gfaf104
The authors review the management of lipid disorders, propose an algorithm useful in clinical practice & call attention toward broader use of novel LLT -
NDT
@NDTsocial
Longitudinal medication adherence in children with nephrotic syndrome and association with disease outcomes
📖doi.org/10.1093/ndt/gfaf105 -
NDT
@NDTsocial
🎥Watch Emilie Cornec-Le Gall present the NDT publication:
Chronic Kidney Disease of unexplained cause ( CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=206ac93… -
NDT
@NDTsocial
Long-term outcomes of IgA nephropathy in China
doi.org/10.1093/ndt/gfae252 -
NDT reposted
Gunnar Henrik Heine
@gunnar_heine
Hello CKDx !
Dr. Halbritter @MuellerRom @LucileFigueres @ecorneclegall and others introduce
"Chronic Kidney Disease of unexplained cause" into nephrology @NDTsocial
Looking forward to host @MuellerRom @ecorneclegall at @MarkusAtHome later this year!
academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf092/8155880 -
NDT
@NDTsocial
🎥Watch Dr Georg Boehmig present the NDT publication:
Antibody-mediated rejection - treatment standard
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=cfcfa34… -
NDT
@NDTsocial
Mineralocorticoid receptor antagonism attenuates arteriovenous fistula stenosis by modulating the phenotype of vascular smooth muscle cells
doi.org/10.1093/ndt/gfae247 -
NDT
@NDTsocial
High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia
🔓doi.org/10.1093/ndt/gfaf101 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘✨Combination therapy and pillars of care for CKD
academic.oup.com/ndt/article/40/Supplement_1/i59/8002192
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
💊Standard of care in CKD
doi.org/10.1093/ndt/gfae258
@NDTsocial @hjanders_hans -
NDT reposted
Brendon Neuen
@brendonneuen
Combination therapy as a new standard of care in CKD - multiple trials testing new therapies in combo with SGLT2i
- ARCTIC/PACIFIC trials: Baxdrostat/dapa vs. dapa
- EASi-KIDNEY: Vicadrostat/empa vs. empa
- ZENITH-HP: Zibotentan/dapa vs. dapa
doi.org/10.1093/ndt/gfae258
#era25 -
NDT
@NDTsocial
🤩Step by the journal's booth at the ERA congress in Vienna and have your picture taken on the NDT cover!
-
NDT
@NDTsocial
Middle cerebral artery aneurysms in older women with autosomal dominant polycystic kidney disease
doi.org/10.1093/ndt/gfaf095
Sex & age significantly affect IA development in patients with ADPKD highlighting the significance of hypertension in older women at risk of MCA aneurysms -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘✨Management of Secondary TMA
doi.org/10.1093/ndt/gfaf091
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
🤔When to suspect Alport Syndrome
doi.org/10.1093/ndt/gfae265
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
🏋️♂️How phyical exercise improves kidney health
doi.org/10.1093/ndt/gfae062
@NDTsocial @hjanders_hans -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in the June edition of @NDTsocial
Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by the IWG of ERA
🧐Not all drugs that reduce UPCR may be disease-modifying. SGLT2i are a DMAND only for GN-related CKD.
academic.oup.com/ndt/article/40/6/1243/8005963 -
NDT
@NDTsocial
🥳Check out the new June issue of NDT!
academic.oup.com/ndt/issue
🧐Editor's choice:
Diagnosis, management and treatment of the Alport syndrome – 2024 guideline on behalf of ERKNet, ERA and ESPN
doi.org/10.1093/ndt/gfae265 -
NDT
@NDTsocial
A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality
doi.org/10.1093/ndt/gfaf094 -
NDT
@NDTsocial
Membranous nephropathy treatment standard
🧐What are the novel developments in the pathophysiology of MN including the identification of target antigens and current treatment standards for MN?
👇👇👇
doi.org/10.1093/ndt/gfad225 -
NDT
@NDTsocial
Is high measured GFR a predictor of all-cause mortality and cardiovascular disease in non-diabetic population? 🤔
@NDTsocial @hjanders_hans @ERAkidney
🧵by @smirioglu
doi.org/10.1093/ndt/gfaf079Post not available here, view on X
NDT
@NDTsocial
Key findings:
🔑A high mGFR or eGFRcys is not associated with an increased risk of CVD or all-cause mortality in the general non-diabetic population with normal urine ACR.
🔑In persons with high-normal ACR, high mGFR or eGFRcys is associated with an increased risk of CVD.
NDT
@NDTsocial
Check @NDTsocial for more content from the Journal!
-
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘Renal Amyloidosis
academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
🎥Watch the authors present their NDT publication:
Bioimpedance-derived euvolemic weight varies in hemodialysis patients - challenging the fixed target weight concept
👇👇👇
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=eeb9727… -
NDT
@NDTsocial
Physical exercise: a polypill against chronic kidney disease
doi.org/10.1093/ndt/gfae062
➡️The authors summarize currently available evidence on the association between physical activity and CKD, and also review the effects of exercise intervention in affected patients -
NDT reposted
-
NDT reposted
Jasmine Sethi
@JasmineNephro
🧬Complement cascade in C3 Glomerulopathy
doi.org/10.1093/ndt/gfad182
@NDTsocial @hjanders_hans -
NDT reposted
Jasmine Sethi
@JasmineNephro
👍Approach to Nephrotic syndrome based on anti nephrin antibody🆕
@NDTsocial @hjanders_hans
doi.org/10.1093/ndt/gfae166 -
NDT
@NDTsocial
C3G and Ig-MPGN—treatment standard
doi.org/10.1093/ndt/gfad182
➡️The authors review the current standards of treatment and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management of C3G and Ig-MPGN -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘✨Pathophysiology of PGNMID
doi.org/10.3390/cells14090668
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Kidney stone biology: insights from genetics
doi.org/10.1093/ndt/gfaf062
This review describes the relevant biology of nephrolithiasis, leveraging ‘experiments of nature’, specifically the known genetic associations of KSD and the resulting biological and physiological derangements -
NDT
@NDTsocial
🎥Watch Dr Jialin Han present the NDT publication:
Are patients with primary glomerular disease at increased risk of malignancy?
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b1c9720… -
NDT reposted
Neveen Soliman
@neveenase
Recently published in @NDTsocial
The study improves the clinical and #genetic characterization of the #rare TRPC6 #podocytopathies
@ISNeducation @IPNA_PedNeph @johnasayer @drjosflynn @rupeshrainamd @EAE_Elhassan
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf… -
NDT
@NDTsocial
Hypertension in chronic kidney disease—treatment standard
🔓doi.org/10.1093/ndt/gfad118
The authors review the current standards of treatment and discuss novel developments in pathophysiology, diagnosis, outcome prediction and management of hypertension in patients with CKD -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
How to individualize renoprotective therapy in obese pts with CKD
👍Multitarget therapy incl. RASi, SGLT2i, GLP-1ra and nsMRAs improve MACE and MAKE in pts with overweight/obesity and T2DM
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf069/8129710 -
NDT
@NDTsocial
🎥Watch Dr Jose Manuel Arreola Guerra present the NDT publication:
Association of perinatal exposition to xenobiotics with kidney volume at birth
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=58f00af… -
NDT
@NDTsocial
Acute kidney injury, acute kidney disease, and chronic kidney disease: challenges and research perspectives
doi.org/10.1093/ndt/gfaf090 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘Hypertension in CKD Management
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfae…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
Complement activation in secondary thrombotic microangiopathies
doi.org/10.1093/ndt/gfaf091
This Review summarizes the current understanding and future directions in the management of secondary TMA, emphasizing the potential of complement inhibition as therapeutic strategy -
NDT reposted
Gunnar Henrik Heine
@gunnar_heine
Lupus weeks @MarkusAtHome:
Tonight 7:30 CEST (and later on demand) @BradRovin Dr. Ana Malvar
REGENCY
Next Friday 7:30 CEST (and later on demand)
@AliDuarteMD
Glucocorticoid Therapy in SLE Patients
with @NDTsocial @hjanders_hans @AKronbichler Kirsten de Groot -
NDT reposted
Jasmine Sethi
@JasmineNephro
🔥Approach to MPGN on kidney biopsy
🙇♀️Rule out secondary causes
1️⃣Post infectious GN
2️⃣Autoimmune Ds
3️⃣Infections-endocarditis/HBV/HCV/HIV/abscess
4️⃣Monoclonal Gammopathy
@NDTsocial @hjanders_hans
doi.org/10.1093/ndt/gfad182 -
NDT
@NDTsocial
🎥Watch Dr Remi Brasme present the NDT publication:
Recurrence of CKD-associated pruritus after discontinuation of Difelikefalin
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=84c15ec… -
NDT
@NDTsocial
How to individualise renoprotective therapy in obese patients with chronic kidney disease
➡️a commentary by the Diabesity Working Group of the ERA @ERAkidney
🔓doi.org/10.1093/ndt/gfaf069 -
NDT
@NDTsocial
High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort
doi.org/10.1093/ndt/gfaf079 -
NDT
@NDTsocial
🎥Watch Dr Peter Kotanko present the NDT publication:
The uremic solute 3-carboxy-4-methyl-5-propyl-2-furanpropionate ( CMPF ) may enhance eryptosis and increase erythrocyte osmotic fragility through potential activation of Piezo1
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c332548… -
NDT
@NDTsocial
KIDNEY AGING and CHRONIC KIDNEY DISEASE - Another Perspective
doi.org/10.1093/ndt/gfaf087
In Nephrology, should we persist in a paradigm with one singular, generalized GFR threshold for the CKD definition, irrespective of such important factors like age, sex or body mass? -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
🫁Lungs & Kidneys🫘: A toxic tango!
💨 Hypoxemia, 🌫️ hypercapnia & endothelial chaos in CLD set the stage for AKI 🥴—often overlooked, yet deadly
A must-see schematic for all!
#nephrology #medtwitter #aki #pulmrenal #criticalcare
🔗doi.org/10.1093/ndt/gfaf077 🆕 @NDTsocial -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘✨Rituximab monotherapy in new onset Minimal change disease
👏Impressive results
@NDTsocial @hjanders_hans
academic.oup.com/ndt/article/39/5/893/7529214 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘‼️ Point of care creatinine testing POCT
⏩Fast/ can be done bedside
academic.oup.com/ndt/article/40/5/839/7929022
@NDTsocial @hjanders_hans -
NDT reposted
Dr. Hardik Patel 🩺💉
@hardik4u24
"Rituximab: A New Frontier for Minimal Change Disease!
This groundbreaking study found that rituximab monotherapy induced rapid remission in 88.9% of new-onset adult minimal change disease patients within a year! 🎉
#nephrology
#mcd #rituximab
@NDTsocial @ERAkidney -
NDT
@NDTsocial
♥️Selected from our cardio-kidney collection:
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction
🆓doi.org/10.1093/ndt/gfae019
📸Possible mechanisms explaining increased erythropoiesis following therapy with SGLT2 inhibitors -
NDT
@NDTsocial
🎥Watch Dr Mathijs van Oevelen present the NDT publication:
Health-related quality of life and symptom burden in patients on haemodialysis
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=b462c48… -
NDT
@NDTsocial
ABCDE to identify & prevent chronic kidney disease: a call to action
A) Albumin in my urine?
B) What is my Blood pressure?
C) What is my Cholesterol?
D) Do I have Diabetes?
E) What is my current kidney function (Estimated glomerular filtration rate)?
doi.org/10.1093/ndt/gfaf057 -
NDT
@NDTsocial
🎥Watch Dr Spela Bogataj present the NDT publication:
Intradialytic cycling and cognitive training to mitigate decreased functional and physiological status in haemodialysis patients
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=e6c409a… -
NDT
@NDTsocial
The role of nutritional vitamin D in chronic kidney disease–mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation
➡️a European consensus statement
🆓doi.org/10.1093/ndt/gfae293 -
NDT
@NDTsocial
🎥Watch Dr Enrique Morales present the NDT publication:
How to individualise renoprotective therapy in obese patients with chronic kidney disease:
a commentary by the Diabesity Working Group of the ERA
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=27c409a… -
NDT
@NDTsocial
Matrix metalloproteinase-(MMP)10 aggravates podocyte injury in glomerulonephritis
doi.org/10.1093/ndt/gfaf076
GC-A ablation leads to upregulation of MMP-10 resulting in nephrin loss & that systemic deletion of MMP-10 ameliorates GC-A-induced podocyte injury -
NDT reposted
Jasmine Sethi
@JasmineNephro
😶🌫️🫘Cognitive impairment assessment in CKD
doi.org/10.1093/ndt/gfae256
@NDTsocial @hjanders_hans -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Optimal Glucocorticoid Therapy in Lupus Nephritis
🧐The review examines different dosing strategies, including IV pulse and oral regimens, and presents evidence of their efficacy and safety.
▶️academic.oup.com/ndt/article-abstract/doi/10.1093/ndt/gfa… -
NDT
@NDTsocial
Tailored management strategies for IgA nephropathy based on clinical presentations
🆓doi.org/10.1093/ndt/gfae289
This Review proposes therapeutic algorithms to guide treatment decisions in different clinical scenarios while highlighting gaps in current research -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫘 Tunnelled dialysis catheter insertion standard
academic.oup.com/ndt/article/40/2/264/7734777
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
🎥Watch Dr Matias Trillini present the NDT publication:
THE FUTURE OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN CARDIOVASCULAR–KIDNEY–METABOLIC DISEASES – CONSIDERATIONS FROM THE ERA DIABESITY WORKING GROUP
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=a24077d… -
NDT
@NDTsocial
Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients
doi.org/10.1093/ndt/gfaf078 -
NDT
@NDTsocial
Global epidemiology of kidney cancer
🆓doi.org/10.1093/ndt/gfae036 -
NDT
@NDTsocial
CKD progression, kidney failure, and mortality among US patients with IgA nephropathy
doi.org/10.1093/ndt/gfaf084 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🫀🫘Management heart failure with CKD
@NDTsocial @hjanders_hans
academic.oup.com/ndt/article/38/8/1798/6998568 -
NDT
@NDTsocial
🎥Watch Dr Ditte Hansen present the NDT publication:
A multidisciplinary team approach for CKD-associated osteoporosis: a special report by the CKD-MBD Working Group of ERA
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=705c51e… -
NDT
@NDTsocial
Chronic lung diseases and kidney disease: pathophysiology and management
doi.org/10.1093/ndt/gfaf077 -
NDT
@NDTsocial
🤩Check out the new May issue of NDT!
academic.oup.com/ndt/issue -
NDT
@NDTsocial
Cardiovascular involvement in ANCA-associated vasculitis
doi.org/10.1093/ndt/gfaf070 -
NDT
@NDTsocial
Acute kidney injury in very old patients - incidence, severity, risk factors and short-term outcomes
doi.org/10.1093/ndt/gfaf074 -
NDT
@NDTsocial
🎥Watch Dr Xianhui Qin present the NDT publication:
Association of dietary vitamin E and tocopherol isoform intake with kidney disease progression in patients with chronic kidney disease
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=987a5a3… -
NDT
@NDTsocial
Temporal trends in the treatment of relapsing minimal change podocytopathy
doi.org/10.1093/ndt/gfaf072
➡️The treatment of relapses in MCD has changed since 2010 with reduced use of prednisolone monotherapy & cyclophosphamide & increased use of CNI & rituximab -
NDT reposted
Gopambuj Singh Rathod
@IamGopambuj
🧠❌ 🥔 Seizures in Kidney Diseases -
🥵 Can occur due to kidney non specific and kidney specific causes
🌀 Approach is slightly different for AKI, ESRD and Post transplant patients
💊 Modification of drug dosing is the key
Read in detail in this excellent review doi.org/10.1093/ndt/gfab283
@NDTsocial
#nephtwitter #medtwitter #kidney #neurology #gsr #buddingnephros -
NDT
@NDTsocial
🎥Watch Dr Andrea Spasiano present the NDT publication:
Kidney Stone Biology: insights from Genetics
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=ed9397a… -
NDT
@NDTsocial
Cognitive impairment in chronic kidney disease:
role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors
🔓doi.org/10.1093/ndt/gfae256 -
NDT
@NDTsocial
Functional outcomes in pediatric patients on kidney replacement therapy in a worldwide registry
doi.org/10.1093/ndt/gfaf067 -
NDT
@NDTsocial
A meta-analysis of graft survival, patient survival, and delayed graft function in first-time and repeat kidney transplants
🆓doi.org/10.1093/ndt/gfaf066 -
NDT
@NDTsocial
🎥Watch Paul Geertsema present the NDT publication:
The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=9626e54… -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now online in @NDTsocial
Early identification of CKD in pts with a solitary functioning kidney
🧐There is a need for long-term follow-up protocols in congenital single kidney pts from pediatric to adult nephrology care
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf063/8116273 -
NDT reposted
Jasmine Sethi
@JasmineNephro
💎🫘Evaluation of renal stone disease in adults
Stone analysis 🧐
Blood 🧪 labs
Genetics 🧬
academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfae…
@NDTsocial @hjanders_hans -
NDT
@NDTsocial
🎥Watch Dr Katherine Tuttle present the NDT publication:
CKD screening for better kidney health: Why? Who? How? When?
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=44eced1… -
NDT
@NDTsocial
Cardio-Kidney Outcomes for Combined versus Monotherapy with Finerenone or SGLT2 Inhibitors in Patients with CKD
🔓doi.org/10.1093/ndt/gfaf064 -
NDT
@NDTsocial
🤩EDITORIAL FELLOWSHIP CALL 2025🤩
🤝Interested in becoming an NDT Editorial Fellow and being involved in all aspects of medical publishing?
Just go to:
academic.oup.com/ndt/pages/editorial-fellowship-call-2025 -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Glucocorticoids-induced remission followed by RTX as maintenance therapy for minimal change podocytopathy in adults
🧐RTX > GC in terms of efficacy and safety for maintaining remission and preventing relapse
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf050/8113979 -
NDT
@NDTsocial
🧐Selected from our joint ERA and ESC Cardio-Kidney Collection:
academic.oup.com/ndt/pages/joint-era-and-esc-cardio-kidne…
❤️Proximal versus distal diuretics in congestive heart failure
doi.org/10.1093/ndt/gfae058 -
NDT
@NDTsocial
Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions in adults: a randomized controlled trial
🔓doi.org/10.1093/ndt/gfae208 -
NDT reposted
Jasmine Sethi
@JasmineNephro
🔥🧐When to suspect renal artery stenosis
💥Resistant hypertension/Worsening of existing hypertension
💥Kidney size difference >1.5 cm
💥Flash pulmonary edema
💥>30% kidney function decline after starting ACEi/ARB
@NDTsocial @hjanders_hans
academic.oup.com/ndt/article/38/12/2835/7172140 -
NDT reposted
Gopambuj Singh Rathod
@IamGopambuj
🌀Proximal tubules in health and disease
✔️ Transport function
✔️ Endocytosis of filtered protein
✔️ SGLT2i site of action
✔️ Tubular secretion of various substances
✔️ Role in kidney injury and repair
Read in detail - doi.org/10.1093/ndt/gfae177
@NDTsocial
#nephrology #nephtwitter #medtwitter #basics #gsr #buddingnephros -
NDT
@NDTsocial
Hyperkalemia and maintenance of renin–angiotensin system inhibitor therapy after initiating SGLT-2 or DPP-4 inhibitors
doi.org/10.1093/ndt/gfae227 -
NDT
@NDTsocial
Effect of pharmacist interventions in chronic kidney disease: a meta-analysis
doi.org/10.1093/ndt/gfae221 -
NDT
@NDTsocial
🎥Watch Dr Turgay Saritas present the NDT publication:
Kidney expert consultation and the outcomes of in hospital acute kidney injury
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=bec1f06… -
NDT reposted
Gunnar Henrik Heine
@gunnar_heine
The next step for nephroprotection in #adpkd?
EMPA-CKD, DAPA-CKD and STOP-CKD will tell!
Now @NDTsocial - Soon @MarkusAtHome
Merci à & Dank an @ecorneclegall @MuellerRom @dguerrot Roland Schmitt et al.
Academic partner: @AKronbichler @hjanders_hans
academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf061/8108808 -
NDT
@NDTsocial
🧐Selected from April issue NDT:
academic.oup.com/ndt/issue/40/4
Translational research on cognitive impairment in chronic kidney disease
doi.org/10.1093/ndt/gfae229 -
NDT
@NDTsocial
🎥Watch Charles Ferro present the NDT publication:
ABCDE to identify and prevent chronic kidney disease: a call to action
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=f630ebb…
@ERAkidney -
NDT reposted
Jasmine Sethi
@JasmineNephro
😳🫘SGLT2 inhibitors in ADPKD
doi.org/10.1093/ndt/gfaf061
@NDTsocial @hjanders_hans -
NDT reposted
Hans-Joachim Anders
@hjanders_hans
Now open access in @NDTsocial
Maintaining kidney health in aging societies: a JSN and ERA call to action
🧐 Don`t miss the opportunities for intervention
▶️academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf068/8110686 -
NDT
@NDTsocial
🎥Watch Drs Martine Knol and Maatje van Gastel present the NDT publication:
Higher beta-hydroxybutyrate ketone levels associated with a slower kidney function decline in ADPKD
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c6ce509… -
NDT
@NDTsocial
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial
🔓doi.org/10.1093/ndt/gfae203 -
NDT
@NDTsocial
🤔Hydroxychloroquine for all patients with lupus nephritis?
Check out the pros and cons in NDT:
doi.org/10.1093/ndt/gfae280
doi.org/10.1093/ndt/gfae254 -
NDT
@NDTsocial
🎥Watch Dr Laura Labriola present the NDT publication:
Infectious complications associated to buttonhole cannulation of native arteriovenous fistulas: a 22-year follow-up
oup.cloud.panopto.eu/Panopto/Pages/Viewer.aspx?id=c56042f… -
NDT
@NDTsocial
SGLT2 inhibition for patients with ADPKD – closing the evidence gap
🔓doi.org/10.1093/ndt/gfaf061
This review summarizes the current knowledge on SGLT2i in ADPKD patients & outlines the clinical trial programs in different geographic regions aiming to make SGLT2i accessible -
NDT
@NDTsocial
♥️ Beautiful and effective♥️:
what art can do for nephrologists and for our patients
The authors describe ways in which art can help nephrologists cope with pressures in their professional lives and add a patient perspective
🆓doi.org/10.1093/ndt/gfad228 -
NDT
@NDTsocial
NEW Editorial in #ndt #openaccess 👌:
Long- or short-acting erythropoiesis-stimulating agents: take no shortcuts in their evaluation!
📖academic.oup.com/ndt/article/doi/10.1093/ndt/gfaa118/5862350🔓
#esa @gstrip3















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































